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Abstract 
Toxoplasma gondii is an obligate intracellular parasite with the ability to infect 
most warm-blooded vertebrates. It propagates mitotically as a haploid cell during most of 
its life cycle. Serological studies indicate that the prevalence of infection by Toxoplasma 
ranges from 20 to 80% in different populations. Although it is typically benign in healthy 
adults, it causes severe life-threatening infection, toxoplasmosis, in neonates and 
immunocompromised patients. T. gondii infection has emerged as one of the most 
common opportunistic infection in AIDS patients. 
Little is known about specific molecules of parasite necessary for invasion and 
maintenance of its intracellular survival. A major surface antigen of 30kDa (P30) was 
isolated and its gene was cloned as surface antigen gene 1 (SAGl). P30 is highly 
immunogenic to seropositive sera to both acute and chronic infected animals and humans. 
Immunization of P30 with appropriate adjuvants can protect mice against lethal 
challenge. It is thus a prosperous diagnostic agent and subunit vaccine. 
In this experiment, the P30 gene was obtained by PGR on the genomic DNA of a 
Toxoplasma isolated from an infected woman in China (ZSl). It was also virulent to 
mice. The P30 gene was modified such that its hydrophobic C and N termini were 
removed and tagged with 6 histidine residues (his-tag) and an enterokinase cleavage site. 
The modified P30 fusion gene was subcloned into bacterial and plant expression vectors 
(pET-30a(+) and V7). These recombinant plasmids were transferred into bacteria and 
plant for the production of recombinant his-tag P30. 
The his-tag P30 was expressed by IPTG induction as 32 kDa protein in SDS-
PAGE. It constituted over 20% of the total proteins in E. coli. It was purified into high 
homogeneity from bacterial lysate using TALON resin. It existed as inclusion body and 
thus could be purified by differential centrifugation. The his-tag P30 could recognize the 
seropositive sera of mice, rabbit and human. Antiserum was raised against his-tag P30 
vii 
from mice. This antiserum could detect P30 antigen of T. gondii lysate (35 kDa) in SDS-
PAGE. 
Besides, P30 fusion gene was introduced into the genome of Arabidopsis thaliana 
by Agrobacterium-rnQdmitd transformation via vacuum infiltraton. Transgenic plants 
with single copy of transgene were selected and propagated so that three transgenic plants 
(F2 and F3 generations) were obtained. By using PGR and southern blot on the genomic 
DNA of F3 plants, single copy of transgene at different positions in plant genome was 
detected. Transgene RNA expression was detected in F2 and F3 transgenic plants by 
northern blot and RT-PCR respectively. The protein profiles of F3 and FO plants were 
compared by means of SDS-PAGE and western blot. Up to now, the his-tag P30 protein 
could not be detected from transgenic plant extracts. More works should be done to 
confirm whether the protein expression level of his-tag P30 was too low to be detected 


















合的 P30 (his tag P30)� 
H i s t a g P 3 0在大腸杆菌C O " )中的表達量爲總蛋白的 2 0 %以上，並且可 
以從菌體裂解液中只經過TALON樹脂一步純化，便能-得高純度蛋白(在SDS-PAGE 
的分析中，his t a g P30的純度爲95%以上）° H i s t a g P30是以包涵體形式表達， 
並可以通過差速離心得以純化。His t a g P 3 0中的P 3 0可以通過內腸激酸的消化 
ix 
去掉組氨酸尾來獲得，得到的P30可以識別陽性的鼠血淸，兔血淸和人血淸。而 
抗重組的his t a g P30血淸專一性很強，可以識別弓形蟲體裂解液中的P30° 
另外，通過真空濾入農杆菌介導的轉化，his t a g P30基因被轉入南京芥菜 
{Arabidopsis thaliana)的基因組中。只有含單拷貝的轉入基因植物被選出來進 
行繁殖，從而就得出三個細胞系。經PCR和Southern blot証實了轉入基因確實 
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Chapter 1 General Introduction 
1.1 Biology of Toxoplasma gondii 
Toxoplasmosis is an infection affecting almost all warm-blooded animal 
species (review by Dubey et al., 1988; Kasper and Boothroyd，1993). The causative 
agent of the disease is an obligate intracellular parasite. It was discovered 
simultaneously in 1908 at the Tunis Pasteur Institute in the wild rodent and in Brazil 
in a laboratory rabbit. As it was arc-shaped (Toxo - arc ； plasma - form, Greek) and 
discovered from a rodent (Ctenodaciylus gondii), it was named Toxoplasma gondii. 
Serologic evidence indicates a high rate of human exposure to the organism. 
Throughout the United States, there are 20 to 70% of the population serologically 
positive for T. gondii. Although most infections are benign or produce no symptoms, 
an infection is frequently encountered among two groups of high-risk individuals. In 
human fetuses, Toxoplasma infection may result in severe congenital defects or even 
death when the mother has been infected during pregnancy. Another group belongs to 
immunocompromised persons. Patients with certain kind of cancers (e.g. lymphoma), 
organ transplantation or acquired immunodeficiency syndrome (AIDS) have high 
incidence of opportunistic infection (e.g. toxoplasmic encephalitis). As the number of 
people in these two groups is increasing, it is important to have a better understanding 
of the biology of this organism and the treatment of toxoplasmosis. 
This general introduction is divided into two main parts. The first part will 
focus on the biology of T. gondii : its forms and host ranges during its life cycle and 
the technologies developed to elucidate the biological processes of the parasite. The 
second part of the introduction will focus on the development of Toxoplasma 
vaccine. 
1 
1.1.1 Life Cycle of Toxoplasma gondii 
The mode of transmission of T. gondii remained unclear until its life cycle was 
elucidated (Frenkel et al., 1970; Dubey et al, 1970; Sheffield and Melton, 1970). T. 
gondii is an intracellular coccidian. Felines, mainly domestic cats, are the definitive 
hosts and infected through ingestion of oocysts or bradyzoites. These parasites invade 
intestinal mucosal cells and undergo both asexual schizogonic cycle and sexual 
gametogonic cycle, which result in the formation of oocysts and eventually shed with 
the cat feces. 
Each oocyst has eight sporozoites within two sporocysts. Once the oocyst is 
sporulated, sporozoites develop and remain viable for 1 year or more in moist 
environment. In intermediate host, T. gondii undergoes asexual multiplication by 
endodyogeny with two parasite forms: (a) tachyzoite, the rapidly dividing form which 
responses to acute infection and (b) bradyzoite, the slowly dividing encysted form 
which is characteristic to chronic phase of toxoplasmosis. Bradyzoite persists for the 
lifetime of the host. Once the bradyzoite cyst is formed, the asexual cycle is complete 
(review by Dubey et al, 1998; Dubey，1998). 
Three methods of transmission are possible. It may be (1) acquired by 
ingestion of oocysts from the cat feces; (2) acquired by the ingestion of bradyzoite 
cyst from infected meat, inadequately cooked; or (3) congenital transmission occurs in 
humans and many animal species. The interrelationship of the various hosts in the 
propagation of the parasite and its transmission are illustrated in Fig. 1.1. 
Asexual cycle Sexual cycle 
Intermediate host Definitive host 
(warm-blooded animals (Cat) 
Ingestion 
Bradyzoites in ^ Gut infection 
tissue cysts t I 
Tachzyoites ^ “ Oocysts m feaces 
Ingestion 
Figuare 1.1. Life cycle of Toxoplasma gondii. 
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(a) Tachyzoite 
Tachyzoite (tachos = speed in Greek) refers to the stage in which the parasites 
multiply rapidly in any cell types of the intermediate host and in nonintestinal 
epithelial cells of the definitive host. It is arc-shaped with 2-3 i m wide and 4-8 i m 
long. The ultrastmcture of the tachyzoite is typical of the Apicomplexa. At its anterior 
pole, it has a typical apical complex consisting of three distinct morphological 
components : (a) Conoid which is a tmnicated cone of spirally arranged fibrillar 
structure, (b) Polar ring complex which encircles the anterior tip, and (c) Distinct 
secretory organelles including rhoptries, micronemes and dense granules which may 
be involved in invasion. 
Tachyzoites move by gliding and enter the host cells by active penetration 
through host cell membrane. After entering the host cell, the tachyzoite becomes 
ovoid and is surrounded by a parasitophorous vacuole (PV), which appears to be 
derived from both the parasite and the host cell. Soon after penetration, a 
tubulovesicular membranous network (TMN) develops within the PV. It multiplies 
asexually within host cell by repeated endodyogeny. Finally, the tachyzoite causes 
rupture of the host cell membrane and the released tachyzoites infect adjacent 
uninfected host cells. 
(b) Bradyzoite 
After the rapid multiplication and invasion into the host cell, an immune 
response of the host begins to develop. Then tachyzoites will eventually differentiate 
into the slowly dividing form, bradyzoite. Bradyzoite (brady = slow in Greek) is to 
describe the organism which multiply slowly within a tissue cyst. 
Bradyzoite structurally differs only slightly from the tachyzoite. They are 
slender and smaller in size. Bradyzoite is divided by endodyogeny and bound within a 
thin wall to form a tissue cyst. Although bradyzoites are apparently harmless, 
sequestered within dormant cysts, a persistent immunity to T. gondii is required to 
avoid reemergence of the tachyzoite stage and accompanying pathologic changes. 
3 
1.1.2 Genetics of Toxoplasma gondii 
Toxoplasma well suited for genetic studies. First，the parasite can easily be 
maintained in vitro and grow productively in virtually any cell line. Therefore, mutant 
can be produced and propagated as clone. In addition，replicative stage of the parasite 
is haploid. It has no worry about the mutations being recessive to a wild-type allele. 
Hence, phenotypic analysis of mutants is relatively easy. Sexual cycle was found to 
occur in feline primary hosts. Classical genetic studies can be conducted easilty with 
the availability of rudimentary genetic and physical linkage maps. The molecular 
genetic studies can further be facilitated by DNA transformation using a variety of 
selectable markers. Particularly the oocysts apparently contain all the progeny of the 
meiotic process, analogous to tetrad analysis of the fungal asci. 
In addition, the gain of knowledge on Toxoplasma research may benefit to the 
knowledge of closely related pathogens such as Plasmodium falciparum. The efforts 
on study will be accelerated with the uses of molecular biology techniques. 
(a) Population genetics 
Studies on population genetics are important to understand the 
epidemiological and biological aspects of parasitic infection (review by Darde，1996). 
Different polymorphic markers were devised for analyzing population structures. 
Kasper's group (Kasper, 1989) firstly used specific monoclonal antibodies to study 
the antigenic differences among the different strains of T. gondii. Besides, from 
isoenzyme studies the existence of genetic polymorphism among seven isolates was 
first confirmed and showed low degree of genetic diversity among Toxoplasma strains 
(Darde et al., 1988; Darde et al., 1992). Restriction fragment length 
polymorphism (RFLP) markers could characterize successfully the population 
structure of Toxoplasma gondii (Silbey et al, 1992). In addition, the technique of 
random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR) was 
also used to detect DNA polymorphisms among T. gondii strains (Guo and Johnson, 
1995). 
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Protozoan parasites usually contained linear chromosomes. It would not 
condense in mitosis and thus excluded conventional light microscopic analysis. A 
molecular karyotype for Toxoplasma gondii was constructed based on separation of 
chromosomes by transverse alternating field electrophoresis (TAPE) and assignment 
of linkage groups by hybridization (Silbey and Boothroyd，1992). Therefore, a 
restriction fragment length polymorphism linkage map for T. gondii was generated 
which consisted of 11 linkage groups (Silbey and Boothroyd, 1992). Virulent strains 
of T. gondii was suggested to originate from a single lineage. It remained genetically 
homogeneous despite being globally widespread, and despite the ability of this 
organism to reproduce sexually (Silbey et al., 1992b). 
From further phylogenetic analysis of 106 Toxoplasma gondii strains based on 
RFLP, T. gondii has a population structure that is highly clonal, comprised of three 
main lineages (Howe and Silbey, 1995). Each lineage has specific biological 
phenotype. Type 1 strains are acute virulent in mice. They show a greater prevalence 
in human cogenital toxoplasmosis than in chronic animal infections. Type II strains 
have a propensity for producing high cyst burdens and chronic pathology in mice. 
They are mostly associated with human toxoplasmosis both in congenital infected and 
immunocompromised patients. Finally, type III strains are abundant in animals, yet 
rarely seen in human toxoplasmosis. Population clonality indicates that sexual 
recombination occurs much less frequently in the population than would be expected. 
Instead, most isolates arise by mitotic expansion of a limited number of genotypes. 
Clonality is likely to persist due to the limited opportunity for meiosis in the wild and 
transmission through food chain by carnivorous feeding or scavenging that propagates 
as mitotically dividing forms. 
(b) Molecular Genetics 
Progress in molecular genetics of Toxoplasma has been particularly rapid in 
the past several years (review by Roos et al., 1994; Boothroyd et al., 1995). 
Molecular genetic tools for analyzing haploid tachyzoite form of T. gondii parasites 
include (i) Transient and stable transformation vectors, (ii) gene knock-out strategies 
and insertional mutagenesis, and (iii) Antisense strategy. 
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Development of molecular trasnsforaiation techniques is highly valuable to 
permit identification of novel targets for the treatment of parasitic disease. In 1993， 
Boothroyd's group had developed a transient transfection and later stable 
transformaton methods by transferring gene constructs into tachzyoite in vitro with 
chloramphenicol acetyltransferase as selectable marker (Solati and Boothroyd, 1993; 
Kim et al., 1993). Later, with the use of a mutant form of dihydrofolate reductase-
thymidylate synthase locus in Toxoplasma gondii as selectable marker, Roos's group 
also developed homologous replacement and gene replacement in Toxoplasma 
tachyzoite (Donald and Roos, 1994). 
Currently, several dominant selectable markers have been developed and are 
being used for stable transformation shown in the following table 1.1. 
Table 1.1. Maker genes available for Toxoplasma research. 
Trasient expression gene Activity Reference 
CAT Chloramphenicol acetyl transferase Soldati and 
Boothroyd, 1993 
LacZ E. coli. P-galactosidase Seeber and 
Boothroyd, 1996 
GFP Green flourescent protein Striepen et al，1998 
Selectable markers gene Selection Reference 
Ble Phieomycin Soldati et al, 1995 
Cat Chloramphenicol Kim et al., 1993 
Dhfr-Pyrr Pyrimethamine Donald and Roos, 1994 
Trp Tryptophan Sibley et al, 1994 
Until recently, a stable episomal shuttle vector for Toxoplasma gondii was 
developed (Black and Boothroyd, 1998). A sequence containing 500-base pair 
fragment was isolated from the Toxoplasma genome through selection for episomal 
stability of a pUC19-based library in the absence of a selectable marker. It showed 
stabilization activity. Using an episomal vector to stably transform a strain would 
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bypass many obstacles such as laborious manipulation of DNA from method of stable 
transfonnaton. Besides, as the vector is easy to recover from the transfonnants and re-
introduce to the parental strains, the function of the gene can easily be elucidated. In 
addition, as the episome does not directly interact with the genome, the probability of 
inducing a mutation as a result of integration is diminished. 
The evaluation of gene function can be performed by phenotypic analysis of 
gene knockouts. By method of stable transfonnaton, knockout mutants of ROPland 
B1 genes were constructed (Kim et al., 1993). As Toxoplasma are haploid, it is useful 
to elucidate the function of gene by nonhomologous. This method is particularly 
useful to clone nonessential genes such as nucleotide salvage pathway enzymes such 
as uracil phosphoribosyltransferase gene (Donald and Roos，1995) and hypoxanthine-
xanthine-guanine phosphoribosyltransferase gene (Donald et al., 1996). Genes related 
to invasion or infection will be the main candidates to be knocked out for assaying 
their functions. 
Studying gene function by antisense RNA technology has recently applied in 
T. gondii research. Antisense RNA to nucleotide triphosphate hydrolase could reduce 
its mRNA leveland resulted in inhibited replication of T. gondii (Nakaar et al., 1999). 
Although the strategy at present is still in infancy, this technology is promising to 
investigate the biological functions of essential genes in T. gondii. 
(c) Genome analysis 
Genetic analysis of the protozoan parasite Toxoplasma gondii has undergone a 
rapid expansion in recent years. An effort to create an extensive databases of 
expressed sequence tags (ESTs) for this parasite can promote the rapid discovery of 
genes related to bradyzoite differentiation, phylogenetic studies within apicomplexa, 
rapid mapping of natural polymorphism, and specific organelles such as plastid. 
Currently, there are over 10,000 ESTs derived from RH tachyzoite, ME49 
tachyzoite and ME49 bradyzoite cDNA libraries (Wan et aL, 1996; Ajioka, 1998). As 
ME49 strain showed more ‘complete，differentiation into bradyzoite, it was induced 
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in vitro following 6 days of growth at high pH, more than 95% of the parasite was 
successfully induced to express bradyzoite surface P36 antigen. Besides, mature 
bradyzoites were isolated from the brain of infected mice. As insufficient amount of 
mature bradyzoite was obtained, cDNA was PGR amplified, restriction-digested, size-
fractionated and subcloned into directional library. By this method, a number of 
putative bradyzoite-specific ESTs were found (Manger et al., 1998b). 
Like most protists, the small size of the organisms, the lack of a fossil record， 
and the complexity of their life cycles have hindered establishing taxonomic scheme. 
By searching EST databases, a newly recognized class of genes was identified 
apparently restricted to the apicomplexa. As these genes and probably their gene 
functions are common to the members of same phylum, they may be potential targets 
for intervention (Ajioka et al.，1998; Barta, 1997). In addition, some nuclear-
encoded proteins are targeting to plastid organelle to perform fatty acid biosynthesis. 
As these proteins contain signal sequence for targeting, by the same strategy, a group 
of genes encoding for proteins targeting to plastid were found from EST database 
(Waller et al” 1998). 
1.1.3 Invasion 
The interaction between Toxoplasma and its host cells is essential for 
the estabolishment of productive infection (review by Dubremetz, 1995; Dubremetz, 
1998). It is a highly specific process involving sequences of programmed events. 
Motile parasites make contact with host cells via extruded conoid, leading to a distinct 
invagination of the host cell plasma membrane. The parasite moves through a small 
opening or junction in the host cell plasma membrane which undergoes temporary 
deformation in the process and has secretion from the rhoptries occurs during this 
phase. The parasite then resides within the parasitophorous vacuole (PV), which resist 
typical phagosome-lysosome fusion (Sibley and Weidner, 1985). Because there have 
no host proteins found in PV membrane and thus it obviously prevents any fusion 
from the host (Mordue and Sibley, 1997). 
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Although the PV exhibits fusion block, it contains pores and functioned as 
molecular sieve for exchange of molecules up to 13-19kDa (Schwab et al” 1994). 
Similar pore was also found in malaria parasite (Desai and Rosenberg, 1997). It was 
found consistently in close proximity to host cell endoplasmic reticulum and 
mitochondria (Sinai et al, 1997). Thus, these pores may function in metabolite 
uptake, nutrient transport and protein trafficking. Although little is known on origin of 
PV (Suss-Toby et al, 1996; Pacheco-soares and Souza，1998). Once the PV is 
established inside the host cell, it will undergo modification shortly. A prominent 
vesicular network that forms connections with the parasite and the PV membranes, 
called intraphagosomal membrane (IPM) or tubulo-vesicular network. 
1.1.4 Surface of Toxoplasma gondii 
The parasite surface is considered to play a key role in the invasion process of 
the organism and is indeed a major target of the host immune response. In addition, it 
has been widely studied for their dual potential as diagnostic reagents and as 
immunogens for vaccines. 
The broad host and tissue specificity of Toxoplasma gondii may indicate that 
ligands and receptors mediating initial attachment of T. gondii to host cell are likely to 
be highly conserved and ubiquitously distributed. Owning to the ease of both in vitro 
and in vivo propagation, most of the early studies were focused on the tachyzoite 
surface. With the advance of molecular biology and development of in vitro induction 
of tachyzoite to bradyzote stage, the surface of bradyzoite was being studied 
intensively in recent years (review by Boothroyd et al” 1998; Tomavo, 1996). 
(a) Tachyzoite surface 
Tachyzoites of Toxoplasma gondii have been reported to have five major 
surface antigens (SAG) : P22, P23，P30, P35 and P43 according to their mobilities in 
SDS-polyacrylamide gel electrophoresis (Handman et al., 1980). They can be 
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detected by surface iodination or biotinylation of extracellular parasites. With the use 
of monoclonal antibody, the principal iodinatable surface antigen P30 was purified 
(Kasper et al, 1983). The gene of P30 was cloned by screening RH tachyzoite cDNA 
expression with seropositive serum (Burg et al” 1988) and named as surface antigen 
gene 1 (SAGl) (Silbey et al, 1991). 
By similar method, SAG 2 (P22) and SAG 3 (P43) were cloned (Prince et al., 
1990; Cesbron-Delauw, 1994). It was found that the primary structure of SAGl and 
SAG3 were similar as they had � 2 4 % amino acid homology including conservation of 
all of the cysteines in the mature protein and thus similar secondary and tertiary 
structures. Although SAG2 showed no apparent similarity to SAGl or SAGS, they all 
contained nucleotide sequences putative for anchoring glycosyl-phosphatidylinositol 
(GPI) moieties (Prince et al, 1990). 
GPI-anchored proteins contains a glycan core that links the carboxyl terminus 
of the protein to an inositolphospholipid. The glycan backbone of the parasite anchors 
may be unmodified or substituted with monosaccharides and/or extensive 
oligosaccharide side-chain (review by Low and Saltiel，1988). GPI-anchored proteins 
tend to dominate the surface of parasite and are speculated to perform particular 
functions such as invasion. The major surface antigen, P30, of Toxoplasma gondii 
was found to be GPI anchored (Nagel et al., 1989; Tomavo et al, 1992). However, 
replacing the GPI anchor with a transmembrane domain in Toxoplasma gondii did not 
show significant difference in any aspects of the growth of the mutant but with a 
lower half-life suggesting that a stabilizing function of the glycolipid anchor against 
degradation (Seeber et al” 1998). 
By studying upstream region of SAGl gene, a gene related to SAGl was 
found and called SAGl-related sequence 1 (SRSl) (Hehl et al., 1997). SRSl also 
contained signal peptide and was GPI-anchored on tachyzoite surface. In addition, by 
searching of EST database, four new genes related to SAGl were identified (SRS2, 
SRS3，SRS4 and SRS5) (Manger et al” 1998). They were GPI-anchored. Three of 
them were shown to express on tachyzoite surface. Besides, SRS3 gene was suggested 
to be the originally identified surface antigen，P35. It was thus proposed that a family 
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of GPI-anchored surface antigens would perform particularly functions during 
invasion. 
(b) Bradyzoite surface 
Although the differences of antigens between tachyzoite and bradyzoite were 
reported (Kasper, 1989)，the progress of its surface characterization was limited by 
technical difficulty for isolation of enough bradyzoite. The establishment of culture 
conditions suitable for inducing differentiation of Toxoplasma tachyzoites into 
parasites resembling the latent bradyzoite form has opened this important 
developmental transition to experimental analysis (Soete et ai, 1994). 
With the use of monoclonal specific antibodies, it was found that SAGl and 
SAG2 were not present in bradyzoite while SAGS was present in both tachyzoite and 
bradyzoite. Besides, three bradyzoite specific antigens (P36, P21 and P18) were 
identified by a panel of specific monoclonal antibodies (Tomavo et al, 1991). Gene 
for P18 was cloned and named as SAG4 (Odberg-Ferragut et al” 1996). Using the 
promoters of some bradyzoite-specific genes, bradyzoite-specific expression was 
demonstrated (Bohne et al” 1997). Some developmentally regulated genes such as 
P35 was isolated. It was involved in the differentiation to bradyzoite (Knoll et al., 
1998). In addition, comparison of ESTs with bradyzoites and tachyzoites revealed that 
many previously uncharacterized sequence clusters which are largely specific to a 
particular developmental stage (Manger et al., 1998). Hopefully, with the combination 
of methods, more bradyzoite-specific antigens can be found. 
(c) Sporozite surface 
The sporozite surface is largely unexplored. It is because it is relatively 
difficult to obtain sufficient amount of oocyst. Since after sexual fertilization within 
feline host, the stage of oocyst in feline feces remains for 1-2 weeks. Besides, as it is 
highly infectious, it must be handled with extreme care. The mostly used method is to 
use tachyzoite or bradyzoite-specific antibodies to characterize the surface of 
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sporozite. It was found that SAGl and SAG2 were not present on sporozite and 
confirmed that they were truely tachyzoite specific antigens (Kasper et al., 1983). 
(d) Glycoprotein antigens 
Because carbohydrates are found modifying most cell surface proteins and 
have the greatest potential for structural variety. Studies on glycoprotein may account 
for the unclear phenomenon of some surface protein knock-out mutants. 
The presence of glycosylated polypeptides was first detected by incubation of 
Toxoplasma gondii lysate in gel with radioactively labelled concanavalin A (Con A) 
(Johnson et al, 1981). The presence of monosaccharides as well as the bovine serum 
albumin-glucosamide on culture medium was demonstrated to influence the 
infectibility of Toxoplasma gondii (Crane et al” 1982; Robert et al” 1991). In 
addition, the sulfated polysaccharide on parasite was demonstrated involving in host 
cell infection (Ortega-Barria and Boothroyd, 1999). It could also be revealed by using 
glycolysation mutant (Monteiro et al., 1998). 
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1.2 Treatment of Toxoplasmosis 
1.2.1 Chemotherapy 
As most antitoxoplasma compounds have been discovered by empirical 
screening and adopted from compounds previously used for Plasmodium. It often led 
to poor understanding of the exact mechanism underlying the effects of the drugs 
against the parasite. With the emergence of drug resistance and diminishing chances 
of finding new antitoxoplasma agents by empirical means, rational approach may be 
the preferable way to find new drugs (review by Chang and Pechere, 1993; Gross and 
Pohl, 1996). 
Most of these drugs were suggested to specifically inhibit the metabolism of 
the parasites such as nucleic acid and protein synthesis. Yeast was also used as a 
model system to study drug effectiveness against apicomplexan proteins (Silbey et al” 
1997b). Several in vitro and animal models were established for testing the efficiency 
of drugs against T. gondii. More recently, with the knowledge of genome research on 
T. gondii, some nuclear-encoded genes were found to target on plastid genome. As 
plastid is not present in mammalian hosts, these genes and their products can be a 
target to design new antitoxoplasma drugs (Fichera and Roos, 1997). 
(a) Drugs against metabolism and protein synthesis on nuclear genome 
Although little is known on metabolism of nucleic acid in T. gondii, its rapid 
replication in tachyzoite stage should accomplish a high level of nucleic acid cycling. 
Besides, many antibiotics acting on bacterial ribosomes possess antitoxoplasma 
activity. By exploring the differences between the metabolism of parasite and its host 
and the different affinity of drugs on metabolites in these processes may allow 
desirable drugs for selective inhibition. There are so many drugs shown effective in 
vitro or in vivo, they were listed in the table 1.5. (Chang, 1993). 
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Table 1.5 Antitoxoplasma drugs target on nuclear genome of Toxoplasma gondii. 
狄 、 、 、 、 、 、 、 、 、 、 、 、 、 似 、 、 、 傲 、 、 、 、 似 、 、 傲 、 、 傲 V t f w � 似 、 v w & v 说 、 、 v M a v � w » » » a ^ > » » w w 傲 - 郷 
Name of drug Mechanism Reference 
—f^ SSiSii^ JiSiii^  AntifoiSe Derouin and Chastang, 1989 
Sulfonamide Antifolate 
Spiramycin Inhibitor of protein synthesis 
Dinitroaniline Inhibit spindle formation Stokkermans et al., 1996 
Apicidin Inhibit histone deacetylase Darkin-Rattray et al., 1996 
Trovafloxacin Antibiotics with unknown mechanism Khan et aL, 1996 
Hydroxynaphthoq Inhibit cyst formation with unknown Araujo et al., 1992 
uinone mechanism 
Anticoccidials Unknown mechanism Ricketts and Pfefferkorn, 1993 
Antifolates are analogs on metabolites of folate cycle and used as inhibitors to 
block the folic acid metabolism of parasite (Derouin and Chastang, 1989). 
Pyrimethamine inhibits the enzyme dihydrofolate reductase while sulfonamide is an 
inhibitor of dihydropteroate synthase. As both enzymes are key enzymes in folic acid 
metabolism and have high affinity to drugs than those from the host cell. The 
combination of pyrimethamine with sulfonamide is currently the most effective 
therapy against tachyzoite stage of T. gondii as they provide sequential blockade of 
the folic acid metabolism. However, pyrimethamine is potentially teratogenic and thus 
not suitable for pregnant women. Spiramycin was used as alternate treatment. While, 
use of sulfonamide for long term treatment often results in hypersensitivity, therefore, 
finding of substitutes is an emergent need. 
(b) Drugs against other organelles 
Atovaquone was found active against T. gondii and targeted on mitochondria. 
As mitochondrial electron transport chain serves to generate this membrane potential. 
Maintenance of membrane potential is critical not only for ATP synthesis but also for 
the maintenance of additional metabolic activities of mitochondria. By using a flow 
cytometric assay as an alternate means to study mitochondrial functions, atovaquone 
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collapses the membrane potential and inhibit parasite respiration (Srivastava et al., 
1997). 
Plastid was an organelle found inside T. gondii recently by in situ 
hybridization with plastid-specific probe (Kohler et al, 1997). It was widespread in 
apicomplexan parasite and thus suggested performing essential functions to the 
parasites. As it is absent in mammalian host, it may be target for antitoxoplasma 
drugs. Kinetics of clindamycin action against T. gondii was found to be different to 
drugs target to nuclear metabolism (Pfefferkom et al, 1992; Fichera et al, 1995). 
Similar kinetics were also found in other antibiotics such as azithromycin and 
spriamycin (Pfefferkom and Borotz, 1994). It was found that they inhibited 
replication of plastid and caused a ‘delay-death, phenotype on parasite (Fichera and 
Roos，1997). 
As the plastid contained four membranes and algae-like genes, it was thought 
obtained by second endosymbiosis (Palmer and Delwiche, 1996). Mitochondria, 
chloroplast and plastid were suggested as endosymbiotic organelles. Most of their 
functions were taken up by the nucleus by exchanges of genetics materials or 
cooperation between different organelles. For example, mitochondria-like DNA was 
found in nucleus of T. gondii (Ossorio et al., 1991). 
Nuclear-encoded genes were found to target on plastid of T. gondii (Waller et 
al.’ 1998). All putatively apicoplast-target protein bear N-terminal presequences 
consistent with plastid targeting. Taken the advantage of sequence information of EST 
r. gondii database, candidates targeted to apicoplast were identified in which several 
proteins involved in fatty acid biosynthesis. By using specific inhibitors on 
metabolites and enzymes of fatty acid biosynthesis, blocking of replication of T. 
gondii was observed. It showed an excellent targeting strategy for toxoplasmosis. 
(c) Drug resistance 
Drug resistance is becoming a problem in T. gondii with emergence of 
resistant organism in clinical settings. The problem is complicated by the emphasis on 
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practical aspects but not the mechanisms behind. The emergence of resistance in 
parasite may consist of several key factors. As most parasites are haploid, point 
mutations are immediately phenotypically expressed for traits, which involve single 
genes. Besides, high parasite load in infected person permits high selective pressure 
for emergence of resistant mutant. Along the successful transmission routes, resistant 
trait can rapidly spread out. Furthermore, high genetic adaptability of protozoan 
parasites enables the selection of appropriate strategies to circumvent the lethal effects 
of antiprotozoal compounds such as antifolate resistance (Reynolds and Roos, 1998). 
As T. gondii is an eukaryotic cell, it is not surprising that compounds, which is toxic 
to the parasites, are often toxic for the host cells. Since chemotherapeutic agents 
remain the first-line defence for the treatment of parasitic infections, the problem of 
drug resistance complicates both therapeutic and prophylactic regimens. 
1.2.2 Toxoplasma vaccine 
Antimicrobial therapy, however, is only active against the multiplying and 
metabolically active form of the parasite, but not against the non-multiplying or the 
metabolically inactive form of the parasite. The emergenece of T. gondii as a major 
opportunistic organism in immunocompromised individuals and the steady increase in 
economic losses due to animal toxoplasmosis have fuelled the interest in vaccine 
development. Natural infection with T. gondii gives long-lasting and almost complete 
protection against re-infection, and there is thus reason to believe that toxoplasmosis 
could be prevented by immunoprophylaxis. 
Most vaccines are designed as a prophylactic measure, that is, to stimulate the 
immune response so that on subsequent exposure to the particular infectious agent, 
infection is either prevented or the extent of infection is so low that clinical disease 
does not occur. Mutant strains of T. gondii have been employed in veterinary industry 
as first commercial vaccine (Buxton, 1993). However, the genetic lesions reponsible 
for the attenuation are mostly undefined and results in greater risk of reversion and 
vaccine-induced disease. Genetically engineered vaccines are able to circumvent 
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many of these problems by having defined modifications in these agents, giving them 
specific properties (review by Gordon, 1997). 
(a) Mutant strains of Toxoplasma gondii as vaccine 
For the farming industry, toxoplasmosis is a major cause of economic loss 
through neonatal mortality, particularly in sheep, goats and pigs. Abortion and 
neonatal mortality occur following a primary Toxoplasma infection during pregnancy. 
The objective of vaccination of farm animals is first to reduce abortions resulting 
from transplacental infection of fetuses. Secondly, it is to reduce the risk of human 
exposure resulting from ingestion of infected meat (with the subsequent risk of fetal 
infection). For these purposes, non-persistent strains of T. gondii are vaccine 
candidates. Several mutant strains of T. gondii have been obtained and got a 
promising result in fanning industry. Therefore, it is not only economically important, 
it offers a useful model of human infections. 
(i) Temperature-sensitive mutant (ts-4) 
Mice were immunized with live organisms of the different stages (tachyzoite, 
bradyzoites, or sporozoites) of T. gondii, or with killed tachyzoites with or without 
adjuvants. The protection was measured by challenge with the pathogenic M-7741 
strains in which mutant strain, ts-4, was isolated (Waldeland and Frenkel, 1983). This 
mutant ts-4 is a temperature-sensitive mutant tachyzoite. It does not colonize 
mammalian tissues and forms cyst because of its inability to live and multiply at 
37°C. Subcutaneous inoculation or deposition of the organisms into the duodenum 
and jejunum results in the development of resistance to challenge with lethal strains of 
T. gondii. However, immunization does not prevent formation of cysts by a challenge 
infection (McLeod et al., 1988). 
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(ii) S48 mutant 
An isolate originally named as 56/48 stimulated was isolated by injection of 
mice with inoculum derived from the foetal membranes of an aborted lamb. After 
3000 passages twice per week, it was found that the parasite had lost the ability to 
develop tissue cysts and persistent infection. This mutant was an incomplete 
tachyzoite and named later as S48 (Buxton and Innes, 1995). 
Following subcutaneous injection of S48 into sheep, it multiplies in local 
drainage lymph node, causing a febrile response between days 5 and 10. During this 
time, tachyzoites are present in the blood and antibody can be detected from around 
day 11. T. gondii cannot be recovered from tissues six weeks after injection. The 
protection afforded by one injection of the vaccine is very good for at least 18 months 
after vaccination. Although it has been used as first commercial vaccine in sheep, cyst 
burden seems to be unchanged in newborns of vaccinated animals. Therefore, the 
problem of transmission cannot be solved if the cyst in infected animal tissue has not 
been eradicated. 
(iii) T-263 mutant 
The ingestion of live bradyzoite is necessary to acquire immunity to oocyst 
shedding. A mutant bradyzoite may be an ideal vaccine candidate. T-263 is a 
bradyzoite mutant. It undergoes partial development in the intestine of the animals 
and cannot produce oocysts. Therefore, It can prevent disease in cats and minimize 
oocyst shedding. (Dubey, 1996). Feeding kittens with cysts of T-263 mutant results in 
mild disease and absence of cyst shedding, but does cause development of immune 
responses to T. gondii by animals. 
However, bradyzoites do not survive for more than a few hours at room 
temperature, the vaccine should be kept frozen throughout the manufacturing process. 
Besides, the vaccine consists of live organisms obtained from brains of infected mice 
presents a significant problem in obtaining sufficient quantities. 
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(b) Subunit vaccine 
Antibodies in serum of experimentally infected animals and naturally infected 
humans recognize a number of both cell membrane and cytoplasmic antigens of T. 
gondii tachyzoites. Some of these antigens apparently are recognized by a specific 
class of immunoglobulins and thus suggest their potential use as ligands in 
immunodetection. In addition, the consistent detection of certain immunodominant 
epitopes in T. gondii lysate by these infected sera also suggests that they may be 
useful candidates as subunit vaccine. 
Crude extract of T. gondii has been used to immunize mice for many 
toxoplasmosis studies. Oral immunization of T. gondii sonicate with cholera toxin 
was shown to have significant protection by reducing the parasite load in the mouse 
brain (Bourguin et al., 1993). In addition, crude Toxoplasma extract could also protect 
rats from congenital toxoplasmosis (Zenner et al., 1999). However, the undefined 
composition of the crude Toxoplasma extract made the results complicated and 
inconsistent. Preliminary fractionation of crude extracts had been done and used for 
comparison on their efficiency during vaccination. Different forms, namely soluble, 
excretory/ secretory and cystic, of antigens obtained from T. gondii were 
demonstrated to be effective raising cell-mediated immune response (Rahmah and 
Khaiml, 1992). 
Partially purified antigens of T. gondii were fractionated by SDS-PAGE and 
tested by different immunoassays and lethal challenge on vaccinated mice (Araujo 
and Remington, 1984). By using monoclonal antibody, a cytoplasmic antigen was 
purified and used to immunize mice. Vaccinated mice could prevent lethal challenge 
(Sharma et al” 1984). The protective immunity was later shown to be mediated by 
specific CD4+ T cell (Brinkmann et al., 1993). Soluble fractions of T. gondii antigens 
(STAgs) when entrapped within non-ionic surfactant vesicles (NISV) could 
significantly protect vaccinated mice from congential toxoplasmosis (Roberts et al, 
1994). Besides, souble fraction of T. gondii containing surface antigens when 
incorporated into immunostimulating complexes (ISCOM) could successfully 
immunize mice and protect them from interperitoneal and oral lethal challenges 
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(Lunden et al, 1993). The major antigens incorporated into ISCOM included P30, 
P22 and a glycoprotein antigen with molecular mass of 6,000. 
As antigens responsible for protective immunity were important, many 
different methods were used to purify them as subunit vaccine. With the advance of 
molecular genetics on T. gondii, a lot of surface and excretory/ secretory antigen 
genes had been cloned. Natural or recombinant forms of these antigens have been 
used for vaccination such as GRA 1 (Supply et al., 1999)，GRA2 (Zenner et al； 
1999)，GRA4 (Mevelec et al., 1998), GRA 5 (Zenner et al,, 1999)，R0P2 (Saavedra et 
al” 1996)，SAGl (Bulow and Boothroyd, 1991) and SAG2 (Lunden et al” 1997). 
(c) P30 as subunit vaccine 
The surface antigens of parasite might involve in host immunity and 
pathogenesis of T. gondii infection. P30 was considered to take part in T. gondii 
infection. Monoclonal and polyclonal antibodies to P30 were used in attachment and 
invasion studies (Mineo and Kasper，1994; Grimwood and Smith，1996). It showed 
that P30 was involved in attachment of host cell during T. gondii infection. Besides, 
antisera to P30 also inhibited infection of human fibroblasts and murine enterocytes 
(Mineo et al, 1993). Mutants of T. gondii (P strain) lacking P30 on their surfaces 
were prepared and exhibited decreased virulence in vivo in mice compared to the wild 
type parent (PtgA mutant) (Kim et al., 1992). Although construction of SAGl-
knockout mutants (Kasper et al., 1982; Kasper et al., 1987; Kim et al” 1993), 
knockout mutant of SAGS (SAGl-related) showed decreased virulence in vivo (Kim 
and Boothroyd, 1995; Tomavo, 1996). 
P30 was considered to be ideal candidate for immuno-protection. It was highly 
abundant on surface of tachyzoite and highly conserved among isolates around the 
world (Sibley and Boothroyd, 1992). It was highly immunogenic and was a principal 
antigen recognized by immune sera from animals and human (Pinon et al., 1995; 
Potasman et al., 1986). The monoclonal antibody specific to P30 was protective to 
mice in passive immunization studies (Johnson et al., 1983). Besides, isolated P30 
could stimulate activated macrophage isolated from infected mice (Khan et al., 1988). 
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By adoptive transfer and T-cell depletion studies, the protection was found to be 
mediated by P30 antigen-specific CD8+ T cells. Intranasal immunization of P30 and 
chlorea toxin could also induce mucosal and systemic immune response against 
chronic toxoplasmosis by reducing the development of cerebral cysts (Debrad et al., 
1996). Mice immunized with purified P30 incorporated with liposome as adjuvant 
showed protection against lethal challenge (Bulow and Boothroyd, 1991). Similarly, 
purified P30 adminstered to outbred mice in the presence of the saponin QuilA, was 
able to induce almost 100% protection against acute infection (Khan et al； 1991). 
A multiple antigenic peptide (MAP) was constructed derived from T. gondii 
P30 antigen. A synthetic peptide (P30: 48-67) of P30 was prepared in linear and MAP 
forms. Immunization of mice and rats with this MAP in the presence of incomplete 
freund adjuvant induced an efficient T cell immune response (Darcy et al, 1992). By 
the search of B- and T-cell epitopes on P30，different MAPs have been constructed 
and tested for their antigenicity and immunogenicity (Godard et al, 1994). However, 
they showed high T cell as well as B cell response, immunization of these peptides 
did not show protective effect after oral challenge (Velge-Roussel et al” 1997). 
Besides, one novel approach to confer protective immunity was immunizing mice 
with T. gondii P30 gene-transfected cell line. It induced CD8+ cytotoxic T 
lymphocytes and elicited protective responses to infection with a virulent T. gondii 
RH strain (Aosai et al., 1999). 
On the other hand, recombinant P30 was applied for immunization study. 
Vaccination of E. coli produced P30 with alum as adjuvant was shown to protect mice 
against lethal infection with T, gondii. Immunization of recombinant P30 resulted in a 
significant increased survival after challenge with tachyzoite of RH strains (Petersen 
et al” 1998). Additionally, immunization of recombinant P30 together with 
interleukin-12 could redirect the humoral and cellular immunity toward type 1 pattern 
and reduced the brain parasite load by 40% (Letscher-Bm et al., 1998). By using the 
SBASlc (proprietary composition of SmithKline Biologicals，Rixensart, Belgium) as 
adjuvant to redirect Thl response, the P30 expressed by methylotrophic yeast, Pichia 
pastoris, could also induce effective immune response such that 60% of immunized 
mice still survived after lethal challenge of T. gondii. The level of protection was 
21 
comparable to that performed by immunization of mice with native P30 with Quil A 
(Khan et al., 1991). 
1.3 AIM OF THE STUDY 
Toxoplasma gondii is an obligate intracellular parasite with the ability to infect 
most warm-blooded vertebrates. It can invade almost any nucleated cells by invasion 
and causes severe life-threatening infection, toxoplasmosis, in neonates and 
immunocompromised patients. 
Surface antigen of parasite has been considered involving in infection and 
pathogenesis. P30 is a major surface antigen of T. gondii with molecular mass of 30 
kDa. P30 was highly immunogenic to seropositive sera to both acute and chronic 
infected animals and humans. Immunization of P30 with appropriate adjuvants could 
achieve almost 100% protection of mice against lethal challenge. Therefore, it was a 
prosperous diagnostic agent and subunit vaccine. Production of P30 was the first but 
important step for elucidation of its unctions and applications on various fields. 
Expression of P30 in bacteria as well as in plants was attempted for large-scale 
production of recombinant P30. 
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Chapter 2 Expression of P30 in Escherichia coli 
2.1 INTRODUCTION 
2.1.1 Why Escherichia coli? 
Heterologous gene expression is one of the great achievements of recombinant 
DNA technology. It is employed for the production of recombinant proteins because 
of the convenience of manipulation of these systems, and higher yield. Therefore, it 
is useful for basic research and production of valuable biologicals. Bacterial 
expression system is by far the simplest and most inexpensive means available for 
obtaining large amount of desired polypeptide. 
Escherichia coli is the most frequently used prokaryotic expression system. 
The advanced knowledge and ever-increasing body of information regarding the 
expression of a myriad of different proteins, along with different conditions for 
optimizing their expression have accounted for the preferential use of E. coli as an 
expression host. A large number of commercially available vectors developed 
specifically for the purpose of expression now available, making the development of 
an expression system for a new target protein a more routine procedure. 
As an organism, E. coli is not only easy to grow but their maintenance is 
inexpensive relative to eukaryotic hosts. It allows a large number of experiments to be 
performed quickly during the process of expression optimization. And its simple 
growth requirement makes it easy to scale up for commercial applications. 
The high physiological plasticity of E. coli makes it easy to be engineered on 
genetic levels using the technology currently available. Detailed works have been 
done in E. coli regarding genetic manipulation. The availability of a variety of strong 
promoters and techniques for maximizing translation initiation and elongation, the 
efficient synthesis of heterologous polypeptides in E. coli has become a routine 
matter. By exploiting on promoter function, genetic background and growth 
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conditions, it is now possible to produce proteins at levels as high as 10-30% of the 
cell mass. 
2.1.2 Protein Folding 
Although high level of heterologous gene expression can always be achieved, 
many of the heterologous polypeptides fail to fold into their native state. Given the 
high concentration of total protein in E. coli, proteins emerge from ribosomes as 
unfolded chains with their amino terminus first and are therefore unable to fold stably 
until a domain has been synthesized. Polypeptides potentially interact with each other 
through these hydrophobic surfaces, forming aggregates. This insoluble protein 
aggregates is called inclusion body (Kiefhaber et al” 1991). 
Fortunately, bacteria exhibit a remarkable physiological plasticity, the recent 
development of renaturation procedures and advances in producing correctly folded 
proteins in E. coli by different strategies have greatly improved the situation. 
Co-expression of some proteins aiding protein folding may be another way to 
obtain active recombinant protein (Georgiou and Valax，1996; Thomas et al., 1997). 
In vivo, folding and assembly of polypeptide involves other proteins. These proteins, 
known as ‘molecular chaperones', are thought to temporarily stabilize unfolded or 
partially folded structures and to maintain them in a state competent for subsequent 
folding and assembly (Gething and Sambrook, 1992). The common property shared 
by molecular chaperones is the ability to recognize structural elements exposed in 
unfolded or partially denatured proteins, such as hydrophobic surfaces. They do not 
bind to native proteins and they are capable of interacting with many different 
polypeptide chains without exhibiting an apparent sequence preference. In general, 
co-expression of chaperones and optimization of growth conditions can increase the 
solubility of the recombinant protein (Lawson et al., 1993). 
Another popular strategy designed is fusion of the gene of interest to a second 
‘carrier，or 'partner' gene to produce a fusion protein (review by LaVallie and 
McCoy, 1995). An appropriate gene fusion very often can eliminate variability in 
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expression yields, enables development of generic protein purification schemes and, 
most importantly, successfully prevents inclusion body formation. There are four 
main gene fusion systems for E. coli expression. They are Staphylococcus protein A 
(SPA) (Nilsson and Abrahmsen, 1990), Schistosoma japonicum glutathione-S-
transferase (GST) (Smith and Johnson, 1988), E. coli maltose-binding protein (MBP) 
(Di Guan et al., 1988) and E. coli thioredoxin (LaVallie et al., 1993). These fusion 
systems not only provide high levels of gene expression, but also often produce 
soluble and correctly folded fusion proteins that can be conveniently purified and 
efficiently cleaved. 
2.1.3 T7-based gene expression system 
In recent years, the expression system using the bacteriophage T7 DNA-
dependent RNA polymerase (RNAP) have been used with increasing popularity to 
produce a lot of different proteins in bacterial hosts. As the biology of T7 RNA 
polymerase had been extensively studied so a lot of information and mechanisms had 
been well known (Durbin, 1999). In addition, it only recognizes specific T7 RNA 
polymerase promoter for transcription initiation such property makes it highly 
selective for the expression of cloned gene downstream of the promoter. Besides, such 
promoter is rarely encountered in DNA unrelated to T7 DNA so that it is versatile for 
expression of any genes in bacterial host. Furthermore, there is rare efficient 
terminator for RNAP and thus in most of the case complete transcript of almost any 
DNA can be transcribed. All these characteristics allows RNAP independent of the 
biology of the host. 
The high processive transcription elongation rate compared to the E. coli RNA 
polymerase allows high level transcription and result in up to 50% expression of 
recombinant proteins to the total proteins. The availability of the cloned T7 RNA 
polymerase (Davanloo et al., 1984) and the insensitivity of the polarity RNAP make it 
easy to be a portable expression cassettes; therefore it can be placed in a number of 
vectors and expression hosts (McAllister and Morris, 1991). One of the systems 
developed by Studier is a series of "pET" vectors representing plasmids for 
expression by T7 RNAP (Studier and Moffatt, 1986). 
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(a) Biology of T7 RNA polymerase 
Bacteriophage T7 is a member of Podoviridas family. It has double-stranded 
linear DNA genomes and contains three classes of promoters and genes. Once the 
phage has infected the bacterial host，its class I promoter can recognize the host RNA 
transcription machinery and direct transcription of its own genes. Products of 
bacteriophage genes inactivate host RNAP and phage RNAPs will then drive the 
expression of class II and III genes for its own uses. Class III promoters drive the 
most abundantly expressed gene such as gene 10 of T7 phage for the capsid protein. 
T7 RNAP is a single polypeptide chain of 883 amino acids. It can specifically 
bind to promoter and initiate transcription. Efficiency of transcription is particularly 
dependent on the identity of the nucleotide occupying the +1 position: (G>A>T，C) 
(Martin et al., 1988). Besides, after binding to the promoter to form a catalytically 
active complex, RNAP abortively cycle over the first transcribed nucleotides, called 
initial transcribed sequence ITS before leaving the promoter. It was found that under 
the conditions where abortive cycle is minimal in wild-type polymerase with the 
leader sequence of gene 10 of T7 bacteriophage (Lopez et al, 1997). Escape from 
abortive cycle into elongation phase of transcription is a rate-limiting step in 
transcription. Once the enzyme has escaped, elongation is extraordinary fast. It was 
estimated to be five times faster than E. coli RNAP. 
(b)pET translation vector 
The pET vectors represent plasmids for expression by T7 RNA polymerase 
(Studier and Moffatt, 1986). It contains an origin of replication derived from 
pBR322for maintaining high copy number. The promoter is a class III promoter of 
gene 10 of T7 phage (TAATACGACTCACTAT) encoding for abundant amount of 
capsid protein. The upstream sequence (GATCTCGATC) of 010 promoter can form 
an 8-bp stem-and-loop structure, which confers some as yet undefined advantages 
probably stability or translability. In addition, ribosome binding site can stabilize the 
formation of translation initiation complex and is essential for translation. 
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Leaky expression of cloned gene may be toxic to the host cells. Therefore, a 
tightly repressed expression system was devised, lac operator is added in promoters of 
pET vector and T7 RNAP gene in host genome. It significantly reduces basal 
expression of the target gene in the uninduced cell but seems to have little effect on 
the level on induction. Besides, after addition of stop codons either TAA or TAG in 
three different frames, it follows with a potential stem-and-loop structure, which 
cause efficient termination of transcription of T7 RNAP both in vivo and in vitro. 
(c) Histidine-tagged protein 
Fusion proteins offer a lot of advantages in expression system such as more 
convenient for purification and detection, aiding proper folding and thus making more 
soluble recombinant protein as already described in previous section. It was found 
that histidine and cysteine could form rather stable complex with transition elements 
such as Nicokle in nearly neutral aqueous solution (Porath et al” 1975). The 6 
histidine tagged protein and nicokle resin column used in the experiment is based on 
the high-affinity binding of six consecutive histidine residues (the his-tag) to 
immobilized nickel ions, giving a highly selective interaction. It allows purification of 
tagged proteins or protein complexes from <1% to >95% homogeneity in just one 
step. 
As the tight association between the tag and the resin is independent of the 
tertiary structure of the tag, denatured proteins can be easily purified. The six histidine 
residues are uncharged at physiological pH, and therefore are very poorly 
immunogenic. Consequently, the his tag very rarely affects the structure or function of 
the tagged protein, and even need not be removed after purification. In addition, major 
surface antigen (P190) of Plasmodium falciparum fused with 6xHis tag could be 
successfully expressed and purified. It further strengthened that parasite surface 
antigen could be conveniently expressed in bacteria for analysis (Gentz et al” 1988). 
In addition, methods were developed for the production of clinical grade malaria 
vaccine candidates expressed in E. coli by recombinant DNA technologies. Therefore, 
the same technology may be applicable to other parasite proteins (Takacs and Girard, 
1991). 
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(d)Host strain for expression 
One of the bacterial hosts used in pET system is the B strain BL21. As it is 
deficient in the major ATP-dependent protease, Ion protease in cytoplasm and outer 
membrane protease, ompT protease that can degrade proteins during purification, the 
stability of the recombinant protein can be greatly enhanced. 
Bacteriophage DE3 is a X derivative that has the immunity region of phage 21 
and carries a DNA fragment containing the lad gene, the lac\]W5 promoter, the 
beginning of the lacZ gene, and the gene for T7 RNA polymerase. This fragment is 
inserted into the int gene, and because the int gene is inactivated, DE3 needs a helper 
for excision from chromosome. As the expression host is a lysogen of DE3, it is 
usually called BL21 (DE3). Once DE3 lysogen is formed, the only promoter known to 
direct transcription of T7 RNA polymerase gene is lacUV5 promoter, which is 
inducible by isopropyl-P-D-thiogalactopyranoside (IPTG). 
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2.2 MATERIALS 
2.2.1 Bacterial Strains 
1. Escherichia coli (DH5a) 
2. BL21 (DE3) 
2.2.2 Mouse strain 
1. Balb/c strain 
2.2.3 Chemicals 
1. Acetic acid, glacial Ajax 1 
2. Acrylamide Sigma A8887 
3. Agar (Bacteriological grade) Ajax 863 
4. Ampicillin Sigma A9518 
5. Ammonium persulfate Sigma A7460 
6. Antiform A emulsion Sigma A5758 
7. Bovine serum albumin Sigma B2518 
8. 5-Bromo-4-chloro-3-indolylphosphate (BCIP) Gibco BRL 18280-016 
9. Bromophenol Blue Bio-Rad 161-0404 
10. Calcium chloride, hydrated form Sigma C3881 
11. Chloroform Ajax 152 
12. Coomassie Brilliant Blue R-250 Bio-Rad 161-0400 
13. Ethylenediamine-tetraacetic acid (EDTA) Sigma ED2SS 
14. Ethanol, absolute Ajax 214 
15. Glycerol Sigma G5516 
16. Glycine Sigma G7403 
17. Hydrochloric acid, 36% Ajax 1364 
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18. Isoamyl alcohol Ajax 64 
19. Isopropyl-P-D-thiogalactopyranoside (IPTG) Sigma 16758 
20. Kanamycin Sigma K0879 
21. Magnesium chloride Sigma M9272 
22. Magnesium sulfate Sigma M2773 
23. Manganese chloride, tetrahydrate Sigma M3634 
24. Methanol Ajax 2314 
25. Morpholinopropanesulfonic acid (MOPS) Sigma M8899 
26. Nitroblue tetrazolium Chloride (NBT) Gibco BRL 18280-016 
27. N,N'-Methylene-bis-acrylamide Sigma M7256 
28. Ponceau S Sigma P7170 
29. Rubidium chloride Sigma R2252 
30. Propanol-2-ol / isopropanol Ajax 425 
31. Sodium Chloride Sigma S9625 
32. Sodium phosphate Sigma S0876 
33. TAB buffer Amresco 796 
34. TEMED Pharmacia 17-1312-01 
35. Thimersol Sigma T8784 
36. Trizma Base Sigma T6791 
37. Tryptone Oxoid L42 
38. Tween 20 Sigma P1379 
39. Urea Sigma U5128 
40. Yeast extract Oxoid L21 
41. Complete Freund Adjuvant Sigma F5881 
42. Incomplete Freund Adjuvant Sigma F5506 
2.2.4 Nucleic acids 
1. ATP Pharmacia 27-1006-01 
2. dNTPs Pharmacia 27-2035-03 
3. pBluescript SK (-) Strategene AA0005 
4. pBV220 vector From Dr. Chen 
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5. pET-30a (+) vector Novagen 69909-3 
2.2.5 Kits and Reagents 
1. dRhodamine terminator cycle sequencing kit Perkin Elmer 403044 
2. Protein Assay kit I Bio-Rad 500-0001 
3. Qiaex II gel extraction kit Qiagen 20021 
4. Qiagen plasmid Midi kit Qiagen AIA-12145 
5. Slide-A-Lyzer dialysis kit, 7000 MWCO Pierce 66372 
6. Wizard Plus Minipreps DNA purification system Promega A7500 
7. TALON metal affinity column Clontech 8903-1 
8. TALON affinity resin, 10ml Clontech 8901-1 
9. Centricon-10 Amicon 4250 
2.2.6 Antibodies 
1. Anti-His6, Mouse IgGi Boehringer Mannheim 1922416 
2. Anti-Human Polyvalent Ig-AP Sigma A-3313 
3. Anti-Mouse Polyvalent Ig-AP Sigma A-0162 
4. Anti-Rabbit IgG-AP Boehringer Mannheim 1214632 
5. Seropositive sera of human to T. gondii * 
6. Seropositive sera of rabbit to T. gondii * 
7. Seropositive sera of mouse to T. gondii * 
8. Seronegative sera of human to T. gondii * * 
9. seronegative sera of rabbit to T. gondii ** 
10. Seronegative sera of mouse to T. gondii ** 
*Reagents provided by Dr. Chen from China 
** Reagents provided from Animal mouse of CUHK 
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2.2.7 Solutions 
1. Agarose gel, 1% 1% (w/v) agarose in Ix TAE buffer 
2. LB broth / agar lOg NaCl，lOg Tryptone, 5g Yeast Extract and 15g 
bacterograde agar (for LB agar only). Add with 1 litre of 
distilled water and autoclaved. 
3. LB+AmplOO agar / LB agar/broth was prepared and added with filter-sterilized 
broth ampilicin to final concentration of lOO^ig/ml. 
4. LB+Kan agar / broth LB agar/broth was prepared and added with filter-sterilized 
kanamycin to final concentration of 50^ig/ml. 
5. RF 1 solution lOmM RbCl，50mM MnClz, 30mM potassium acetate (pH 
7.5), lOmM CaCl2,15% (w/v) Glycerol. 
Adjust pH to 5.8 with 0.2M acetic acid and sterilize by 
filtration through a pre-rinsed 0.22^im membrane. 
6. RF 2 solution lOmM MOPS, lOmM RbCl, 75mM CaCl2，15% (w/v) 
Glycerol. 
Adjust pH to final pH 6.8 with NaOH and sterilize by 
filtration through a pre-rinse 0.22|im membrane. 
7. SOB solution 2% Bacto-tryptone, 0.5% Bacto yeast extract, lOmM NaCl, 
2.5mM KCl，lOmM MgCl2, lOmM MgSCU. 
8. SOC solution SOB medium plus 20mM glucose solution 
9. Solution A 30% acrylamide and 0.8% bis-acrylamide 
10. Solution B，100ml 75ml 2M Tris-HCl, pH 8.8，4ml 10% SDS and 21ml H2O 
11. Solution C, 100ml 50ml IM Tris-HCl, pH 6.8, 4ml 10% SDS and 46ml H2O 
12.10% ammonium 0.5g ammonium persulfate and 5ml H2O 
persulfate, 5ml 
13. Electrophoresis buffer 3g Tris，14.4g glycine, Ig SDS and H2O to make 1 litre 
14. 5x SDS gel sample 0.6ml IM Tris-HCl, pH 6.8, 5ml 50% glycerol, 2ml 10% 
buffer, 10ml SDS, 0.5ml 2-mercaptoethanol, 1ml 1% bromophenol blue 
and 0.9ml H2O 
15. lOx TBS buffer 200mM Tris-HCl, pH 7.5 and 5M NaCl 
16. Ix TTBS buffer Ix TBS + 0.05% (v/v) Tween 20 
17. 5% BLOTTO 5% (w/v) Carnation nonfat dry milk, Ix TBS buffer, 0.01% 
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(v/v) antifoam and 0.002% (w/v) thimerosol，store at 4 � � 
18. Transblotting buffer 6g Tris Base, 14.4g Glycine, 200ml Methanol and add H2O 
to make up 1 litre. Do not adjust pH! 
19. Dialysis buffer 50mM Tris-HCl，pH 8.0, 2M Urea 
20. Coomassie blue 0.1% (w/v) Comassie blue, 40% (v/v) methanol, 10% (v/v) 
staining solution acetic acid 
21. Destaining solution 40% (v/v) methanol, 10% acetic acid 
22. Ponceau S staining 0.1% (w/v) Ponceau S in 5% (v/v) acetic acid 
solution 
2.2.8 Enzymes 
1. Enterokinase Boeringer Mannheim 1334-115 
2. Lysozyme Sigma L1526 
3. T4 DNA ligase Pharmacia 27-0870-04 
4. Dra II Amersham E0226Y 
5. EcoRI Pharmacia 27-0854 
6. Hindlll Pharmacia 27-0934 
7. Ncol Promega R6513 
8. Xbal Pharmacia 27-0948 
9. Xhol Pharmacia 27-0950 
2.2.9 Sequencing Primers 
Name of primer Sequence (5，to 3，） 
T7 promoter primer TTA ATA CGA CTC ACT ATA G G ^ 
T7 terminator p r i m e r C T A GTT ATT GCT CAG CGG 
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2.3 METHODS 
2.3.1 Modification of P30 gene 
The P30 gene was obtained from Dr. Chen. It was subcloned into vector 
pBV220 and modified by Caraiel. The plasmids pBV220-ASP30PI and pBV220-
SP30hisAPI were used as starting material in this experiment. The signal peptide (SP) 
and phsophatidylinositol-containing glycolipid (PI) addition signal presented in these 
plasmids were modified to produce pBV220-ASP30hisAPI and subsequently to 
pBV220-ASP30API. The modified P30 cDNA was then placed into a strong bacterial 
expression vector pET to form pET-ASP30API for high level expression of 
recombinant his-tagged P30. The procedures were outlined in Figure 2.1. While the 
restriction map of pET vector was shown in Figure 2.2. 
pBV220- ASP30PI pBV220-SP30hisAPI 
P30 PI ECORI and Drall digestion S P P30 his 
、厂调 . 1 fr 
EcoRI Drl丨 X 广 Ec�m Drill pj丨 Psil 
P30 his pBV220-ASP30hisA PI I 1 EcoRI ^ „ I I Drall psti PstI j PstI digestion and self-religation 
P30 Hindlll 
pBV220-ASP30API | | | J | 
EcoRI Ncol I Drall PstI 
， ^ Ncol and Hindlll digestion 
P30 Hindlll 
pET-ASP30API • • � • … … t … … 
EcoRI Ncol � I Drall PstI 
Figuare 2.1 Outline of the construction of pET-ASP30API. 
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pET-30a-o(+) cloning/expression region 
Figure 2.2 Restriction map of pET-30a (+)• Unique sites are shown on the circle map 
(adopted from http://www.novageiLCom/htnil/vectfranLlitml )• 
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(a) Preparation of recombinant plasmids，pBV220-ASP30PI and pBV220-
SP30hisAPI 
Freshly prepared bacterial colonies were obtained from glycerol stocks. Some 
frozen bacteria-glycerol was scrapped with a sterile inoculation loop and streaked 
onto LB+Kan50 plates. The plates were incubated at 37�C overnight to allow the 
development of bacterial colonies. Single colony was then picked and inoculated into 
15ml LB+Kan50 medium. It was shaken overnight at 37°C Overnight culture of 
DH5a- pBV220-ASP30PI and DH5a-pBV220-SP30hisAPI were prepared. These 
recombinant plasmids were isolated by Wizard™P/w5 Minipreps DNA purification 
system. 
Bacterial cells were pelleted at 1,400 x g for 10 minutes. The cell pellets were 
resuspended in 400^1 of Cell Resuspension Solution and transferred to 1.5ml 
eppendorf tube. 400^x1 Cell Lysis Solution was then added and mixed by gentle 
inversion to lyse the cells. The mixture was incubated at room temperature for 5 
minutes and 400^il of Neutralization solution was added to neutralize the cell lysate 
with immediate gentle inversion. The neutralized lysate was cleared by centrifuging in 
a microcentrifuge at 10,000 x g for 5 minutes. 
All of cleared lysate was carefully removed from each miniprep and 
transferred to the syringe/minicolumn assembly where 1ml of resuspended resin was 
loaded. They were mixed thoroughly by pipetting to enhance binding of plasmid 
DNA to resin. Then vacuum was applied by opening the stopcocks of the vacuum 
manifold and stopped until the sample was completely passed through the column. 
The DNA-bound resin was washed with additional 2m\ of Column Wash Solution and 
dried for 30 seconds by reapplying the vacuum. The minicolumn was removed from 
the syringe barrel and put into a 1.5ml microcentrifuge tube. It was spun for 2 minutes 
at 10,000 X g to remove any residual Column Wash Solution. The minicolumn was 
then transferred to a new microcentrifuge tube and added with 50^ x1 sterile H2O to 
release plasmid DNA from resin. The minicolumn/microcentrifuge tube was spun at 
10,000 X g for 20 seconds to elute plasmid DNA. 5[il of the eluted recombinant 
plasmid DNA prepared by Wizard^^P/M5 Minipreps DNA purification system was 
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added to 495jil of distilled H2O for 100-fold dilution. Then they were taken to 
estimate the quantities of DNA prepared in 15ml culture. The yield of each 
preparation was estimated according to 1 unit A260 = 50^ig /ml double-stranded DNA. 
The ratio A260 to A280 of the sample represents its purity. 
(b) Digestion of pBV220-ASP30PI and pBV220-SP30hisAPI with Drall and EcoRI 
l^ig of recombinant plasmids prepared from 2.3.1.(a) was restriction digested 
by 4 units of Drall and EcoRI in 20|il final volume of Ix One-Phor-All buffer. The 
digestion mix was incubated at 37�C for 2 hours. 15\il of digestion mix was then 
loaded on 1% agarose gel. Restriction digested fragments were resolved by 
electrophoresis, stained with ethdium bromide and visualized under UV illumination. 
(c) Purification of DNA fragments from agarose gel 
After agarose gel electrophoresis, restriction digested fragments were 
resolved, stained and visualized. The smaller sized fragment of pBV220-ASP30PI and 
larger sized fragment of pBV220-SP30hisAPI were excised from the gel by sterile 
blades under UV illumination and purified by QIAEX II Gel Extraction Kit. 
Each gel slice was added with 400^1 of Buffer QXl to solublize the agarose 
matrix. Then 7^ x1 of resuspended QIAEX resin was added and incubated at 50°C for 
10 minutes. For every 2 minutes, the sample was mixed by inversion to keep QIAEX 
resin in suspension and enhance DNA binding. The resin suspension was centrifuged 
for 30 seconds and the supernatant was removed carefully with a pipet. The pellet was 
washed and resuspended successively with SOOjil new buffer QXl once and then 
5 0 0 o f PE buffer twice. Finally, the QIAEX resin was air-dried for 15 minute to 
remove any volatile PE buffer and resuspended with 20s te r i l i zed H2O to elute 
DNA. It was centrifuged for 30 seconds to pellet the resin. The eluted DNA was 
pipetted carefully into a sterile eppendorf tube. 
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(d) Ligation of fragments of pBV220-ASP30PI and pBV220-SP30hisAPI 
7^ x1 of DNA fragments of pBV220-ASP30PI and pBV220-SP30hisAPI 
prepared in 2.3.1(c) were mixed together with 2.5\i\ of One-Phor-All buffer (lOX， 
Promega), of lOmM ATP, 14 Weiss unit of T4 DNA ligase making up the final 
volume to 25^ x1 with sterile H2O. The reaction mix was incubated at for 18 
hours. 
(e) Preparation of DH5a competent cells 
Single DH5a bacterial colony was picked from a SOB agar plate, inoculated 
into 10ml SOB broth and grown for 18 hours at 37°C with shaking. 1 ml of overnight 
culture was added to about 100ml pre-warmed SOB medium and shaken at 37°C until 
the optical density of the culture at 600nm reached 0.5 ( � 4 - 7 x 10 cells per ml). The 
culture was collected and incubated on ice for 15 minutes. The bacterial cells were 
harvested by centrifugation at 7,000 rpm in a JA-20 rotor (Beckman) for 15 minutes 
at 4®C. The cell pellet was resuspended with 30 ml pre-chilled RFl solution. The cell 
suspension was incubated for another 5 minutes on ice before pelleted again with the 
same conditions. The cell pellet was dispersed in 8 ml of pre-chilled RF2 and 
incubated for further 5 minutes on ice. The resulting cell suspension was then pipetted 
in lOO i^l aliquot. The tubes were frozen by liquid nitrogen and kept at -70°C freezer 
as stock of competent cell. 
(f) Transformation of recombinant pBV220-ASP30hisAPI 
An aliquot of competent cell (100jil) removed from -70°C freezer was thawed 
on ice and added with lO^il of ligation mix prepared from 2.3.1(d). The ligation-
competent cell mixture was kept on ice for 1 hour, then heat-shocked at 42°C for 2 
minutes and chilled on ice immediately. It was added with 8 0 0 o f pre-warmed LB 
and shaken vigorously at 37°C for an hour. SOfxl of the culture was plated on 
LB+AmplOO plates and incubated at 37°C overnight. 
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(g) Plasmid preparation of putative pBV220-ASP30API 
Single colony containing pBV220-ASP30hisAPI was picked and inoculated 
into 15ml LB+AmplOO broth. Plasmid was isolated and quantitated. l\ig of putative 
plasmid pBV220-ASP30hisAPI was restriction digested with 4 units of PstI in 20[il 
final volume of Ix buffer H (Promega). It was incubated at 3TC for 3 hours. Then all 
the digestion mix was loaded on 1% agarose gel. The restriction-digested and uncut 
plasmids were resolved by agarose gel electrophoresis. The Pstl-cut fragment of 
pBV220-ASP30hisAPI was excised, purified and eluted into 60^1 sterile H2O. 10\il of 
eluted Pstl-cut fragment of pBV220-ASP30hisAPI was self-religated. Then all the 
ligation mix was used to transform DH5a competent cell. Plasmid of putative 
pBV220-ASP30API was isolated and quantitated. 
(h) Plasmid preparation of pET-ASP30API 
Ijig of pure pET vector in lOjil sterile H2O was used to transform competent 
cell. Plasmid DNA was isolated and quantitated. l^ig of pET-30a(+) vector and 
pBV220-ASP30API was restriction digested by 4 units of Ncol and Hindlll in final 
volume 20^ x1 of Ix One-Phor-All buffer. The digestions were carried out at 3TC for 2 
hours. Similarly, l^ig of pET-30a(+) vector and pBV220-ASP30API was restriction 
cut in the same conditions except only one enzyme either Ncol or Hindlll was used as 
control to check the efficiency of enzymes in Ix One-Phor-All buffer condition. 
All the digestion mix of pET-30a(+) vector and pBV220-ASP30API prepared 
were loaded on 1% agaroase gel to perform gel electrophoresis. The single band of 
NcoI-Hindlll-cut pET-30a(+) and the smallest-sized fragment of pBV220-ASP30API 
were excised, purified and eluted into 40|j1 sterile H2O. eluted DNA of pBV220-
ASP30API was mixed together with 2\i[ of eluted DNA of pET-30a(+) for ligation. 
Then, lO^il of the ligation mix was used to transform DH5a competent cell. Plasmid 
DNA were isolated and quantitated. 
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(i) Cycle sequencing reaction on putative plasmid pET-ASP30API 
Cycle sequencing reaction was performed on putative plasmid pET-ASP30API 
by ABI Prism™ dRhodamine Terminator Cycle Sequencing Ready Reaction Kit. l\ig 
of putative pET-ASP30API was mixed with 8|il of Terminator Ready Reaction Mix， 
and l^il of 3.2 pmole specific primer (T7 promoter and terminator primer) making up 
final volume of 20!il with sterile H2O within a sterile PGR tube. It was mixed well, 
spun and then incubated in a PGR machine (MJ Research) with a cycle sequencing 
thermal profile. The reaction mixture was heated at 96�C for 10 seconds to denature 
plasmid template and then incubated at 50�C for 5 seconds, which allowed specific 
primer to anneal on denatured template. The temperature was then kept at 60°C for 
further 4 minutes to perform dideoxy-terminator sequencing reaction. This thermal 
profile was cycled for 25 times. 
After sequencing reaction, the reaction mix was transferred to a new 
microcentrifuge tube for purification. It was added with 2fxl of 3M sodium acetate 
(pH 4.6) and 50|il of 95% ethanol. The mixture was put on ice for ten minutes and 
spun at 14,000 rpm (10,000 x g) for 30 minutes at 4°C. The supernatent was carefully 
removed and pellet was further rinsed with 250^il pre-chilled 70% ethanol before it 
was dried in a vacuum centrifuge (Savant) for 5 minutes. The dried pellet was then 
resuspended in of Template Suppression reagent and heated at 95°C for two 
minutes. The sample was immediately chilled on ice and then loaded on ABI Prism 
377 DNA Sequencer (Pekin Elmer) for reading the nucleotide sequence. 
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2.3.2 Expression and purification of his-tag P30 
The modified P30 (ASP30API) gene was placed into bacterial expression 
vector pET in which P30 gene was linked with fusion partner. The fusion partner 
contained 6 histindine residues (his-tag) as tag of detection and purification. Besides, 
it also contains an enterokinase cleavage site (EK) so that this fusion partner could be 
cleaved off by enterokinase digestion. The construct pET-ASP30API was transformed 
into expression host BL21 (DE3). Transformed cell was grown and induced to 
expression his-tag P30 by IPTG induction. The his-tag P30 was then purified and 
characterized. 
(a) Expression profile of his-tag P30 production by IPTG induction 
Single BL3 (DE3) colony obtained from Dr. Lam and was used to prepare 
competent cell following the procedure described in 2.3.1(e). Competent DE3 cell 
was transformed with 0.2^g of pET-ASP30API in total lO^il. A single colony from 
overnight grown LB+Kan50 plate was picked and inoculated into 15ml LB+Kan50 
broth overnight at 37�C with shaking. 0.6ml of overnight culture was added to 20ml 
pre-warm LB+Kan50 broth and shaken at 37°C until the optical density at 600nm 
reached 0.8. Then IPTG was added to the culture ImM final concentration. Upon 
IPTG addition, it was shaken for 3 hours. For every 30 minutes, 0.5ml culture was 
taken out and spun. The pellet was resuspended into lOOyd Ix SDS gel sample buffer 
and frozen at -20°C. When samples at all the time points were collected, they were 
boiled for 8 minutes, spun down and analyzed by SDS-polyacrylamide gel 
electrophoresis. 
(b) SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Gel sandwich was assembled according to the manufacturer's instructions. A 
12% separating gel solution was prepared. 4ml of solution A, 2.5ml of solution B and 
3.5ml of H2O were combined in a 50ml falcon tube. 50\i\ of 10% ammonium 
persulfate and 5|il of TEMED were mixed with the solutions in falcon tube by 
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swirling gently to avoid excessive aeration. This mixture was then introduced 
carefully into the gel sandwich using a pipet. When the appropriate amount of 
separating gel solution had been loaded, water-saturated iso-butanol was layered on 
the top of the separating gel to exclude air. The gel was casted at room temperature 
for 30 minutes acrylamide polymerization. 
The top layer iso-butanol was removed by rinsing the gel sandwich 
excessively with distilled water. A 5% stacking gel solution was prepared. 670^ x1 of 
solution A, 1ml of solution C and 2.3ml of H2O were mixed in 15ml falcon. 30^il of 
10% ammonium persulfate and 5\i\ of TEMED were then added. The solutions were 
mixed by gentle swirling and pipetted on top of the polymerized separating gel until 
solution reached top of front plate. Clean comb with ten teeth was carefully inserted 
into the gel sandwich until the bottom of teeth reached top of front plate. The stacking 
gel was allowed to polymerize for 30 minutes at room temperature. 
Once the stacking gel had polymerized, the comb was removed carefully and 
the gel was placed into electrophoresis chamber before being inserted into 
electrophoresis tank. Electrophoresis buffer was added into the tank and used to rinse 
the wells so that any unpolymerized acrylamide was removed. 
of the samples prepared from 2.3.2(a) and board-range protein marker 
were loaded into SDS-polyacrylamide gel to perform gel electrophoresis under 
denaturing conditions at 180 V constant voltage. After the coomissie blue dye front 
was just out the gel, the electricity supply was disconnected and the gel cassette was 
dissembled. The gel was put into coomissie blue solution for 1 hour with gentle 
shaking to stain any proteins. Then it was destained with destaining solution until 
observing distinct protein bands and no blue color on the background of the gel. The 
gel was dried and scanned as record. 
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(c) Purification of his-tag P30 
200ml of IPTG-induced bacterial culture, prepared following procedures 
described in 2.3.2(a), was spun at 10,000 rpm for 15 minutes at 4°C (JA-20, 
Beckman). The pellet was then resuspended in 30ml sonication buffer where 
lysozyme and EDTA were added to final concentration of Img/ml and 0.4mM 
respectively. The resuspended culture was shaken gently for 30 minutes at room 
temperature for lysozyme digestion. It was put on ice and sonicated to lyse the cell by 
5 times of 1 minute- sonication pulse. The lysate was spun again at 10,000 rpm for 20 
minutes at 4°C. The supernatant represented the soluble protein fraction was saved 
while the pellet was washed with 20ml of 0.1% Tween 20 twice. The washed pellet 
was treated by two different methods. 
The pellet was resuspended in inclusion body buffer and spun at 10,000 rpm 
(JA20 rotor, Beckman) for 15 minutes at 4°C. Supernatant was discarded and the 
white pellet was resuspended in Ix SDS gel sample buffer, boiled for 8 minutes and 
then loaded (lane 6) on 12% SDS-PAGE gel for electrophoresis. 
On the other hand, the pellet was solublized by 40ml of lysis buffer and added 
with 1ml of lysis buffer equilibrated TALON metal affinity resin. It was shaken 
gently for 1 hour at room temperature for binding. The resin/lysate was spun at 3,000 
rpm for 5 minutes. The supernatant was carefully removed while the resin was 
washed by 20ml of lysis buffer. It was then transferred to a column with an end cap in 
place and allowed to settle out of suspension. The end cap was then removed to allow 
buffer draining until its level was at the top of the resin bed. The column was washed 
further 10ml lysis buffer until no more drops. Then 5ml elution buffer was added 
carefully to the column. The eluted solution was collected in 1ml fractions by 1.5ml 
eppendorf tubes. Protein content of eluted solution was estimated by protein assay. 
(d) Bradford Protein Microassay (Bio-Rad) 
This protein assay was based on the method of Bradford for determining 
concentration of solubilized protein. Bovine serum albumin (BSA) was used as 
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protein standard. Six dilutions of BSA were prepared in which 0，2，4，6，8 and lO^ig 
of BSA contained in 0.8ml sterile H2O. Besides, the fractions containing desired 
protein visualized by SDS-PAGE were pooled together. lO^il of pooled sample was 
added with 790pil sterile H2O. 200fxl of dye reagent concentrate was added to each 
tube and vortexed. The mixtures were incubated at room temperature for 20 minutes 
and their absorbance at 595nm was measured. Standard curve based on known 
quantities of BSA was plotted such that the concentration of pure his-tag P30 protein 
in each fraction could be estimated from the standard curve. 
2.3.3 Characterization of his-tag P30 
The presence of P30 epitope(s) in purified fusion protein can be demonstrated 
by western blot with seropositive serum from infected animal or patients. The amino 
acid of P30 in fusion protein can also be revealed by amino acid sequencing of 
enterokinase-digested his-tag P30. The antigenicity of this his-tag P30 as vaccine can 
be demonstrated by western blot of T. gondii lysate with antiserum of his-tag P30. 
(a) Western blot of induced bacterial lysate by monoclonal anti-his-tag antibody 
20ml IPTG-induced culture was prepared and pelleted by centrifugation. The 
pellets were resuspended in lOO i^l Ix SDS-gel sample loading buffer and boiled for 8 
minutes. 15jil of the samples was loaded on 12% SDS-polyacrylamide gel for 
electrophoresis. A PVDF membrane was cut to the dimensions of the polyacrylamide 
gel and soaked briefly with methanol for 2 to 3 seconds. The wet PVDF membrane 
was then washed in distilled water for 10 minutes and then kept in transblotting buffer 
until use. After electrophoresis, the proteins in the gel were transferred into the 
pretreated PVDF membrane by a semi-dry electrophoretic transfer cell (BioRad). 
The filter paper was pre-soaked with transblotting buffer and placed onto the 
platinum anode. A clean glass pipet were rolled to remove air bubbles. Then the gel 
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was carefully placed on top and aligned on the center of the pretreated PVDF 
membrane. Another pre-soaked filter paper was placed on top of the gel. Any bubbles 
were excluded by rolling pipet across the sandwich before the cathode was covered on 
the stack. Electro-transfer was performed at constant voltage of 18V for 1 hour at 
room temperature. 
After electro-blotting, the membrane was stained briefly with Ponceau S dye 
for 2 minutes and then destained by distilled water until visualizing any transferred 
proteins. The membrane was then cut into strips, labelled at the top of the strips with 
ball pen and put into 5ml round bottom capped tubes. These strips were firstly 
blocked by 2ml of 5% BLOTTO at room temperature for 1 hour with shaking. 
Appropriate titer of primary antibody was added to the BLOTTO afterwards. In this 
case, the strips were primed with monoclonal anti-his-tag antibody in final 
concentration, 40ug/ml, for 1 hour at room temperature. Unbound antibody on strips 
was removed by successive 5 minutes washes at room temperature. Firstly, they were 
washed with Ix TBS once, Ix TBBS twice and lastly with Ix TBS. Secondary 
antibody conjugated with alkaline phosphatase for color development was added to 
prime on where primary antibody located. In this case, a titer 1:2000 of secondary 
anti-mouse IgGl antibody was added to 5% BLOTTO where the strips were 
incubated and shaken at room temperature for another hour. Similarly the unbound 
secondary antibody was removed by Ix TBS and Ix TBBS. 
The clean and primed strips were equilibrated with buffer 3 for 5 minutes. 
They were then taken into clean plastic petri dish in which 5ml buffer 3 with 20^il of 
75mg/ml of NBT and 15 ^ il of 50mg/ml BCIP was added. Color reaction was carried 
out in the dark for 30 minutes at room temperature. The strips then washed 
extensively with distilled water and dried. 
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(b) Western blot of his-tag protein by seropositive and negative sera of m o u s e� 
rabbit and human. 
2jjig of pure his-tag protein was blotted into PVDF membrane and probed with 
different titers of primary seropositive sera of different species of mammal and 
secondary alkaline phosphatase conjugated antibodies as shown in the Table 2.2. 
Table 2.2 Different titers of primary serpositive sera from human, rabbit and 
mouse and secondary antibody conjugated with alkaline-phosphatase. 
Titer of serum Secondary antibody used Titer of secondary 
antibody 
Seropositive and 1:200 Polyvalent anti-human 1:1000 
seronegative human 1:1000 antibody AP conjugated 
serum 
Serpositive and 1:300 Anti-rabbit IgG-AP 1:2000 
seronegative rabbit 1:500 
serum 
Seropositive and 1:500 Polyvalent anti-mouse 1:2000 
seronegative mouse 1:1000 antibody AP conjugated 
serum 
(c) Enterokinase digestion of putative his-tag P30 
The purified putative his-tag P30 prepared in 2.3.2(c) was dialysed using 
Slide-A-Lyzer dialysis cassette. The cassette was removed from its pouch and slipped 
into the groove of a buoy. It was then immersed in dialysis buffer (50mM Tris-HCl， 
pH 8.0 and 2 M urea) for 1 to 2 minutes before use. The syringe was filled with 
pooled samples and left small amount of air. With the bevel sideways, the tip of the 
needle was inserted through on of the syringe ports located at a top comer of the 
cassette. The sample was injected slowly. The air was withdrawn by pulling up on the 
syringe piston. The syringe needle was removed from the cassette while retaining air 
in the syringe. The sample was dialyzed overnight at 4°C with three changes of buffer 
during the dialysis. After that, the sample was withdrawn from the cassette and 
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concentrated by a Centricon-lO concentrator. The concentrator was spun at 5,000 x g 
(3,000 rpm, JA20 rotor of Beakman) at 4°C until the volume reduced to about 1ml. 
The protein quantity of the dialyzed and purified his-tagged P30 was estimated 
by the Bio-Rad protein assay following the procedures described in 2.3.2(b). 25fxg of 
putative his-tagged P30 was incubated with l.Sjig of enterokinase in a final volume of 
130^1 of 50mM Tris-HCl and 2M urea at 3TC overnight. 20\i\ of the digestion mix 
was pipetted out, mixed with of 5x SDS-gel sample buffer and kept at -2(fC at 
the time intervals: 1，3，6，22 and 32 hours. The samples were boiled for 8 minutes 
and loaded into 15% SDS-PAGE gel following the procedures described in 2.3.2.a 
(iv). 
(d) N'terminal amino acid sequencing of pure and enterokinase-cut Ms-tag P30 
15|ig of pure and 7fig of enterokinase-cut his-tag P30 were loaded on 12% 
SDS-PAGE gel and electrophoresed and then blotted onto PVDF membrane. These 
his-tag protein bands were visualized by Ponceau S stain, excised by sterile blade and 
processed with pre-sequencing procedures. Firstly it was wetted with methanol for 30 
seconds and then put into 15ml falcon tube filled with 10ml distilled H2O. Then it was 
sonicated for approximately 10 minutes in a sonication water bath. Finally, the sample 
was sequenced by HP G1005A Protein Sequencing System (Hewlett Packard). 
(e) Western blot of Toxoplasma gondii lysate by antiserum of recombinant his-
tag P30 
90^ig of pure his-tag P30 was loaded into 15% SDS-PAGE gel for 
electrophoresis and stained with Coomissie blue. The bands of his-tag P30 were 
excised and ground into granules as small as possible by sterile glass slides. The gel 
granules was resuspended into 3ml of Phosphate Buffer saline (PBS) and transferred 
into 5ml sterile syringe. It was mixed thoroughly with 3ml Complete Freund Adjuvant 
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contained in another sterile syringe by a luar lock until white and cloudy emulsion 
appeared. 
For primary immunization, 650^1 of the mixture (corresponding to was 
injected into back of mouse intra-dermally. 8 mice were immunized with the 
emulsified antigen. After 14 d a y s� t h e mice were further immunized with a booster 
injection. In the booster injection, it contained same amount of pure his-tag P30 
prepared by the same procedures but incomplete Freund Adjuvant was used instead of 
complete Freund Adjuvant. After 2 weeks from the second immunization, the mice 
were anaesthetized by choroform. The blood was collected by heart puncture and 
transferred into 1.5ml sterile tubes. It was kept for 1 hour to allow blood clotting and 
then spun at 14,000 rpm for 15 minutes at room temperature. The clarified sera were 
pipetted out, pooled together, divided into 200^1 aliqouts and kept at -20°C for 
storage. 
T. gondii lysate in Ix SDS gel sample buffer was prepared by Dr. Chen. lO^il 
of T. gondii lysate in parallel with 2\ig of pure his-tag P30 was loaded into 12% SDS-
PAGE. After electrophoresis and blotting, they were incubated with 4ml of 5% 
BLOTTO with different titers of serum raised against recombinant his-tag P30. The T. 
gondii lysate was primed with 1:200 titer of serum while pure his-tag P30 was primed 
with 1:8000 titer of serum. After incubating for 1 hour at room temperature, the strips 
were washed and then hybridized with 1:2000 titer of secondary alkaline phosphatase 
conjugated Goat anti-mouse polyvalent antibody for 1 hour before standard washing 
and color development procedures described in 2.3.3(a). The strip containing pure 
recombinant his-tag P30 was developed for 30 minutes in color developing medium 




2.4.1 Modification of P30 gene 
The recombinant plasmid�pBV220-ASP30PI and pBV220-SP30hisAPI, were 
used as a starting material in this experiment. pBV220-ASP30PI was a plasmid in 
which the 5，end signal sequence of the P30 coding sequence was cut but retaining the 
ECORI site before the start codon ATG of the mature peptide. pBV220-SP30hisAPI 
was a plasmid in which the PI signal sequence at 3，end of the coding sequence was 
replaced with a 6-his-tag sequence. There was a unique Dra II site located at the 
middle and EcoRI site at the beginning of the P30 gene. 
The plasmids pBV220-ASP30PI and pBV220-SP30hisAPI were digested by 
Drall and EcoRI and then resolved by agarose gel electrophoresis shown in figure 2.3. 
The smaller-sized band ( � 4 0 0 bp) of pBV220-ASP30PI and larger-sized band (-4500 
bp) of pBV220-SP30hisAPI were excised, purified and ligated to form putative 
pBV220-ASP30hisA. For the construction of pBV220-SP30API, the pBV220-
SP30hisAPI was simply cut by PstI and self-religated. 
According to the restriction map of pBV220 vector, it contained two Hindlll 
sites and one Ncol sites. Thus, after digestion of pBV220-ASP30API with Hindlll and 
Ncol, there would be three restriction fragments. The smallest sized fragment ( � 6 0 0 
bp) was the desired product, ASP30API, shown in figure 2.4. Digestions with no 
enzymes or single enzyme were used as control to check the efficiency of the 
enzymes in the buffer conditions. The truncated P30 gene was then subcloned into 
pET-30a(+) vector. The nucleotide sequence of pET-ASP30API was read by cycle 
sequencing with specific T7 promoter and terminator primers. The nucleotide 
sequences were edited by DNasis's Contig Manger program and shown in figure 2.5. 
The quality and quantity of each recombinant plasmid prepared in different sections 
were shown in table 2.2. 
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Table 2.2 Spectrophotometric measurement of recombinant plasmid prepared 
from different sections of chapter 2. 5^ x1 of the eluted recombinant plasmid DNA prepared 
by Wizard™P/M5 Minipreps DNA purification system was added to 495^ x1 of distilled H2O for 
100-fold dilution. Then they were taken to estimate the quantities of DNA prepared in 15ml 
culture. The yield of each preparation was estimated according to 1 unit A260 = 50 i^g /ml 
double-stranded DNA. The ratio Azeoto A280 of the sample represents its purity. 
Name of recombinant A260I Mso Concentration Yield (fig) Reference 
plasmid DNA ("g/"/) 
pBV220-ASP30PI 0：^  403 2.3.1(a) 
pBV220-SP30hisAPI 1.716 0.49 36.8 2.3.1(a) 
pBV220-ASP30hisAPI 1.737 0.425 34 2.3.1(g) 
pBV220-ASP30API 1.797 0.655 49 2.3.1(g) 
pET vector 1.702 0.245 17.6 2.3.2(h) 
pET-ASP30API 1.791 0.22 13.2 2.3.2(h) 
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Figure 2.3 Digestion of pBV220-ASP30PI and pBV220-SP30hisAPI with DraH and 
EcoRI. 2\ig of recombinant plasmid of pBV220-ASP30PI and pBV220-SP30hisAPI was cut 
by Drall (lane 2 and 6)，EcoRI (lane 3 and 7) and Drall + EcoRI (lane 4 and 8) in final 
volume of 40^x1 of Ix One-Phor-All buffer at 37°C for 2 hours. Plamsids pBV220-ASP30PI 
(lanel) or pBV220-SP30hisAPI (lane 5) under same conditions except no enzymes were used 
as control. 25|_xl of the digestion mix was loaded on 1% sterile agarose gel with IxTAE buffer, 
resolved by agarose gel electrophoresis and visualized by ethdium bromide staining and U V 
illumination. M= Ikb plus D N A marker. The size of marker was indicated as nucleotide base 
pair (bp). 
51 
DET-30a(+) vector DBV220- A SP30API 
M 1 2 3 4 5 6 7 8 
pair 
Hindin-NcoI-cut 







Figuare 2.4 Digestion of pET-30a(+) vector and pBV220-ASP30API with HindlH and 
Ncol. 2\xg ofpET vector and pBV220-ASP30API was digested with Hindlll alone (lane 2 and 
6) or Ncol alone (lane 3 and 7) or no enzyme as control (lane 1 and 5) or both Hindlll + Ncol 
(lane 4 and 8) in 40|j1 of Ix One-Phor-All buffer (Pharmacia). They were incubated at 37°C 
for 2 hours. lO i^l of the digestion mix from each sample was loaded on 1% agarose gel, 
resolved by electrophoresis, stained by ethdium bromdie and visualized by UV illumination. 























Figuare 2.5 Nucleotide sequence of pET-ASP30APL The sequence read by T7 promoter 
and terminator primers were edited and manipulated by Contig Manager program of DNasis. 
The bold letters represented the 6xhistidine tagged (his-tag) and enterokinase recogation 
sequences in pET vector. The complete coding sequence of P30 was flanked by start (ATG) 
and stop codons (TAA). The Ncol site (CCATGG) and Hindlll (AAGCTT) was underlined. 
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2.4.2 Expression, purification and characteriziation of his-tag P30 in bacteria 
The pET-ASP30API was transformed into bacterial expression host BL21 
(DE3). Transformed cell was induced by IPTG to express his-tag P30. Expression 
profile of his-tag P30 protein was determined and shown in figure 2.6. It was 32 kDa 
and existed in a form of inclusion body. It could be purified by TALON's affinity 
resin (figure 2.7) and differential centrifugation (figure 2.8). The amount of his-tag 
P30 purified by TALON affinity resin was estimated by bradford protein assay with 
BSA protein as standard (figure 2.9). Referring to the standard curve, the 
concentration of his-tag P30 was 0.891 |ig / i^l. 
The histidine tail of his-tag P30 was detected by monoclonal anti-his-tag 
antibody (figure 2.10). The his-tag P30 read by N-terminal amino acid sequencing. It 
indirectly by T. gon必/-specific antibodies or directly by. It contained. P30 was highly 
immunogenic to sera from infected animals or human. The P30 component in his-tag 
P30 could also be detected by seropositive sera of mammals infected with 
Toxoplasma gondii (figure 2.11). The fusion tag of his-tag P30 was removed by 
enterokinase so that its size was changed from 32 to 22 kDa (figure 2.12). The pure 
and enterokinase-cut his-tag P30 were subjected to N-terminal amino acid sequencing 
with 15 and 13 cycles respectively (table 2.4 and table 2.5). 
Antiserum against the recombinant his-tag P30 was produced and used to 
detect P30 protein in T. gondii lysate. This antiserum could detect P30 antigen in T. 
gondii lysate with a molecular weight of 35 kDa under reducing condition (figure 
2.13). 
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Figuare 2.6 Expression profile of his-tag P30 by IPTG induction. 20ml bacterial 
culture of BL21 (DE3) at ODgoonm^ O.S was added with IPTG to final concentration of ImM. It 
was shaken vigorously at 37�C for 3 hours. For every 30 minutes, 500^1 of the culture was 
pipetted out and spun at 14,000 rpm for 5 minutes at room temperature. Supernatant was 
discarded. The pellet was suspended with 1ml Ix SDS gel sample buffer and stored at -20�C. 
When all time points were collected, they were boiled for 8 minutes. 15|li1 of the sample at 
different time points was loaded on 12% SDS-PAGE gel for electrophoresis. Lane 2 (U) was 
uninduced bacterial culture. Lane 3 to 8 were induced cell culture harvested at the time after 
IPTG induction (lane 3 to 8 = 0.5, 1, 1.5, 2, 2.5, 3 hours). The gel was stained by Coomassie 
blue , destained and then dried. Gel image was captured by scanning. M=Broad-range Protein 
marker (BioRad) and the size of protein marker was indicated as kDa and shown on the left. 
The putative his-tag P30 (~32kDa) was indicated by an arrow. 
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Figuare 2.7 Purification of his-tag P30 by T A L O N affinity column. The induced cell 
was harvested (lane 1). After digestion of lysozyme and sonication, the lysate was spun. The 
supernatant was collected and regarded as soluble lysed-cell fraction (lane 2). While the pellet 
was regarded as insoluble fraction which was washed twice with 0.1 % Tween 20. After each 
wash, the supernatant was collected (lane 3二first wash and lane 4=second wash). Then the 
washed insoluble pellet was solubilized in denaturing buffer with 8M urea (lane 5) and 
purified by TALON' resin. The solubilized solution was mixed with 1 ml TALON resin and 
shaken at room temperature for 1 hour. The mixture was then loaded into gravity column until 
to more drops. It was washed with 10 ml lysis buffer. The rein-bound protein was eluted with 
5 ml elution buffer and collected into 1 ml fractions. The eluted fractions containing proteins 
was pooled together (lane 6). lOfil of samples collected during the purification process was 
mixed with 2.5|al 5x SDS sample buffer and boiled for 8 minutes. They were then loaded on 
12% SDS-PAGE gel for electrophoresis. The gel was stained by Coomassie blue , destained 
and then dried. Gel image was captured by scanning. M=Broad-range Protein marker 
(BioRad) and the size of protein marker was indicated as kDa and shown on the left. The 
putative his-tag P30 ( � 3 2 k D a ) was indicated by an arrow. 
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Figuare 2.9 Purification of his-tag P30 by differential centrifugation. Induced 
bacterial cells were harvested (lane 1). After digestion of lysozyme and sonication, the soluble 
lysed cell fraction was collected (lane 2). While the insoluble fraction was washed twice with 
0.1% Tween 20 (lane 3 and 4). Then the washed insoluble pellet was resuspended in inclusion 
body buffer and spun at 10,000 rpm (JA20 rotor, Beckman) for 15 minutes at 4°C. 
Supernatant was discarded and the white pellet was resuspended in Ix SDS gel sample buffer, 
boiled for 8 minutes and then loaded (lane 6) on 12% SDS-PAGE gel for electrophoresis. The 
putative his-tag P30 protein band was indicated by an arrow. M二Broad Range Protein 
Marker. 
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Table 2.3 Table of Broadford protein assay (BioRad) result. The amount of protein 
standard (Bovine serum albumin, BSA) and putative his-tag P30 in 1ml solution were 
prepared. Their corresponding absorbance values at 595nm after Broad protein assay were 
recorded. 
Amount of Protein in 1ml solution Absorbance at 595nm 
“ OngBSA 0.02 
2 lag BSA 0.043 
4 ng BSA 0.215 
6 lag BSA 0.338 
8 \ig BSA 0.446 
10 i^ g BSA 0.534 
10 [i\ purified his-tag P30 0.486 
Bradford Protei n Assay 
0.6 J � 
: I 0.5 Z ； : ^ : i 0.4 ^ ^ 1 
i 1 
I � 3 Z 丨 
I 一 一 ^ 0 ^ 1 1 1 1 1 1 
0 2 4 6 8 10 12 
- 0 . 1 -L ： 
BSA(ug/n^) 
Figure 2.8 Standard curve of Broadford protein assay. Six dilutions of BSA were 
prepared in which 0，2, 4，6, 8 and lOng of BSA contained in 0.8ml sterile H2O. lO i^l of 
pooled sample was added with 790 i^l sterile H2O. 200^1 of dye reagent concentrate was added 
to each tube and vortexed. The mixtures were incubated at room temperature for 20 minutes 
and their absorbance at 595nm was measured. Standard curve based on known quantities of 
BSA was plotted such that the concentration of pure his-tag P30 protein was estimated from 
the standard curve. 
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Figure 2.10 Western blot of uninduced and induced bacterial lysate with monoclonal 
anti-his-tag antibody. 20ml of bacterial culture (ODeoonm = 0.6) was added with IPTG to 
ImM final concentration. It was shaken at 37°C for 2 hours. Bacterial cultures with or without 
IPTG addition were collected (IPTG-induced and uninduced lysates). 500|al of the cultures 
were taken out and spun. The bacterial pellets were resuspended in lOOjal of Ix SDS sample 
buffer. 15|il of the induced and uninduced samples was loaded on 12% SDS-PAGE gel for 
electrophoresis. The resolved proteins were then transferred to PVDF membrane and 
hybridized with monoclonal anti-his-tag antibody. The arrow indicated the positive signal 
corresponding to the size of putative his-tag P30 (32 kDa). 
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Figure 2.11 Western blots of pure his-tag P30 with seropositive and seronegative sera 
from rabbit, mice and human. of pure his-tag protein was blotted into PVDF 
membrane and probed with different antibodies. Primary antibodies of different species of 
mammal (both seropositive and seronegative sera) were used to probe with his-tag P30. 
Secondary antibodies conjugated with alkaline phosphatase were used for color development 
and detection of signals. The titers of using different antibodies were shown in table 2.2. The 
left side of each picture was the strip subject to higher titer of primary antibodies. 
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Figure 2.12 Enterokinase digestion of his-tag P30. 25|ig of purified his-tag P30 was 
digested with LS^g enterokinase at 37�C in total ISOjiil 50mM Tris-HCl (pH 8.0) and 2M 
urea. 20|li1 of the digestion mix was pipetted out at particular time intervals (0，1，3，6，22, and 
32 hours), mixed with 5|li1 5x SDS-gel sample buffer and boiled for 8 minutes. 15^1 of all the 
samples were then loaded in 12% SDS-PAGE gel. The arrows indicated the size of the 
products (kDa). The 32 kDa protein was the putative his-tag P30 while the 22 kDa protein 
was the putative enterokinase-digested his-tag P30. 
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Table 2.4 N-terminal amino acid sequence of putative his-tag P30. The putative 32 
kDa his-tag P30 was excised from the PVDF membrane and sequenced by the automated HP 
G1005A N-terminal protein sequencing system (Hewlett Packard). 
N-terminal amino acid Deduced amino acid Sequence of pure his-tag P30 
1 Methionine (M) Methionine (M) 
2 一 Histidine (H) Histidine (H) 
3 — Histidine (H) Histidine (H) 
4 — Histidine (H) Histidine (H) 
5 — Histidine (H) Histidine (H) 
6 — Histidine (H) Histidine (H) 
7 — Histidine (H) Histidine (H) 
8 — Serine (S) Serine (S) 
9 一 Serine (S) Serine (S) 
10 — Glycine (G) Glycine (G) 
11 Leucine (L) Leucine (L) 
12 Valine (V) Valine (V) 
13 Proline (P) Proline (P) 
14 Arginine (R) Arginine (R) 
— 15 Gl;cine (G) Glycine (G) 
Table 2.5 N-terminal amino acid sequence of putative enterokinase-cut his-tag P30. 
The putative 22 kDa enterokinase (EK)-cut his-tag P30 was excised from the PVDF 
membrane and sequenced by the automated HP G1005A N-terminal protein sequencing 
system (Hewlett Packard). 
N-terminal amino acid Deduced amino add Sequence of EK-cut his-tag 
P30 
1 Alanine (A) Alanine (A) 
2 Methionine (M) Methionine (M) 
3 一 Glycine (G) Glycine (G) 
4 Phenylallanine (F) Phenylallanine (F) 
5 Threonine (T) Threonine (T) 
6 Leucine (L) Leucine (L) 
7 — Lysine (K) Lysine (K) 
8 Cysteine (C) Undetermined 
9 Proline (P) Proline (P) 
10 一 Lysine (K) Lysine (K) 
11 Threonine (T) Threonine (T) 
12 Alanine (A) Alanine (A) 
^ Leucine (L) [ Leucine (L) 
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Figure 2.13 SDS-PAGE and Western blot of T, gondii lysate with polyclonal 
antiserum against his-tag P30. 12% SDS-PAGE gel stained with Coomassie blue was 
shown on left in which 10|LI1 of T. gondii lysate was loaded and run parallel with broad range 
protein marker (BioRad). The gel was transferred into a PVDF membrane to perform western 
blot. 90|a,g his-tag P30 was used to raise antiserum from mice. The western blot of his-tag P30 
(2 i^g) and T. gondii lysate with polyclonal his-tag P30 antiserum (titer for his-tag P30 was 
1:8000 while titer for T. gondii lysate was 1:200) was shown on the right. The his-tag P30 
was used as positive control for the specificity of the antiserum. Its size was 35 kDa indicated 
by the arrow. This antiserum could recognize the P30 surface antigen of T. gondii under 
denaturing conditions. M=Broad-range Protein marker (BioRad) and the size of protein 
marker was indicated as kDa and shown on the left. 
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2.5 DISCUSSION 
2.5.1 Modification of P30 gene 
A T. gondii china isolate was firstly obtained from an infected woman in 
Zhong Shan University of Medical Science and designated as ZSl. It was virulent to 
mice so that infected mice normally died within days and cysts could be found within 
brain tissues. (Chen et al., 1994 ； Chen et al., 1999). P30 gene was amplified from 
genomic DNA of ZSl strain and subcloned into temperature-inducible bacteria 
expression vector (pBV220). Histidine-tag P30 (his-tag P30) was expressed in 
bacteria but the yield was low (Chen et al., 1994). It was because pBV220 was not a 
strong expression vector. In addition, inclusion of hydrophobic N and C termini 
(Signal peptide and GPI anchor) in P30 gene was not desirable. 
The P30 gene contained signal peptide where two ATG start codons were 
present (Burg et al., 1988). Removal of first ATG was necessary for efficient 
translation of recombinant P30 (Kim et al” 1994). Besides, GPI anchor was present in 
P30 gene (Nagel and Boothroyd�1989). This GPI anchor was found not to determine 
overall three-dimensional structure (Seeber et al, 1998). Thus removal of 
hydrophobic C terminus and replaced with a stop codon ensure enhanced expression 
without interfering the complex structure of P30 (Xiong et al., 1993; unpublished 
observation of Boothroyd et al.). 
In this experiment, the P30 gene was modified such that both hydrophobic N 
and C termini were removed. The modified P30 was then subcloned into another 
bacterial expression vector, pET-30a (+) previously mentioned. The modified P30 
gene was fused with fusion partners in its front. This fusion partner contained 6 
histidine residues (his-tag), thrombin, S tag and enterokinase site and added about 220 
nucleotide bases to the P30 gene. Three components of this fusion partners, his-tag, 
thrombin and S tag, provided a ligand not only facilitating purification but also 
detection of the fusion protein. 
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By comparing the coding sequence of P30 in pET vector with published 
sequence of RH, there were two differences of nucleotide bases. The first change was 
located corresponding to second amino acid of mature his-tag P30 (ATG TCA) where 
TCG was changed to TCA intentionally by a synthetic oligonucleotide. It resulted in 
creation of a new Afl I restriction site but no change on the amino acid residue 
(serine). Another base difference was the substitution at 519 position where it changes 
from G to A. But the amino acid was still threonine (Chen et al； 1994). This 
substitution was believed to be genetic difference between RH and ZSl strain. 
Difference between RH and ZSl strains could also be revealed by comparison of 
R0P2 gene. Two substitutions of R0P2 gene of ZSl were present at bases 678 and 
753 from C—T and T—G respectively. But the amino acids in these two sites were 
the same (unpublished observation of Dr. Fung). From the sequencing result of ZSl 
strain P 3 0 � i t was identical in amino acid sequence to RH strain and contained 12 
cysteines throughout the sequence. Therefore, they shared similar three-dimensional 
structures (Cesbron-Delauw et al” 1994). 
The 3，end of P30 gene was suggested to be a virulence factor of T. gondii 
strain. Five polymorphic sites were suggested: 1241，1273, 1284, 1412 and 1439 
bases according to P30 gene of RH strain (Kinder et al” 1995). From the P30 gene of 
ZSl strain, three of them were found (1241，1273 and 1284). Additional sequence at 
3' end of P30 gene from ZSl strain should be obtained for comparison of other two 
polymorphic sites. Besides, from the comparison among RH as well as two China 
isolates (ZS2 and SH-1-1986)，one T substitution found in ZS2 and SH-1-1986 
isolates at base 1412 polymorphic site when compared with RH strain. Comparison at 
base 1412 polymorphic site was useful to deduce interrelationship among China 
isolates. Because only virulent strains had A nucleotide base at base 1439 while all 
non-virulent strains had G substitution. Therefore, comparison at base 1439 could 
indirectly indicate ZSl was virulent. Besides, comprehensive analysis could be 
performed with the use of PCR-RFLP at 6 loci (SAGl，SAG2，ROPl，850，L328 and 
62)，which had already been used for phylogenetic studies of T. gondii (Sibley and 
Boothroyd, 1992b; Howe and Sibley�1995). 
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2.5.2 Expression and purification of his-tag P30 
After IPTG induction, his-tag P30 was expressed at maximal level after 2 
hours. The expression level was over 20% of the total proteins. Therefore, milligram 
of recombinant protein can be easily produced per milliliter of induced bacterial 
culture (figure 2.9). 
After lys is� the his-tag P30 remained insoluble and existed in a form of 
inclusion body. It was denatured and solubilized by 8M urea. As the binding ability of 
TALON resin was unaffected under denaturing condition and had high affinity to bind 
histidine residues so that it was used to purify his-tag P30. Resin-bound his-tag P30 
could either be eluted by changing pH (pH from 7 to 8) or addition of competing salt 
(imidazole). The method of change of pH in buffer had been tried but it was not as 
good as expected (unpulished observation of Dr. Yu). On the other hand, the result of 
using competing salt was good and simple. Imidazole was a salt, which competed 
with the his-tag P30 for binding to TALON resin. So pure his-tag P30 could easily be 
obtained by elution of buffer containing imidazole. Although low concentration (10 to 
15mM) was able to elute his-tag P30, lOOmM was used to ensure compmlete elution. 
The his-tag P30 could be purified from bacterial lysate to nearly homogeneity of more 
than 95% purity by one-step TALON resin binding. No contaminant was detected 
even by silver stain (data not shown). The 32kDa band was the his-tag P30. While 
another small-sized protein band was the degradated products of his-tag P30. 
Degradation could be minimized if the sample was always kept on ice during the 
purification process. 
It was estimated that 1ml resin was able to bind with 3.6 milligram (figure 
2.10). Although the binding capacity was high, 1ml resin would become saturated 
with small volume of IPTG-induced bacterial culture. It was not economical to purify 
his-tag P30 in large scale. Therefore, another characteristic of the recombinant protein 
was used for purification purpose. As his-tag P30 was aggregated to become insoluble 
inclusion body, it was expected to be heavier than other cellular proteins of bacteria. 
Under specific centrifugation conditions, the inclusion body was be isolated to nearly 
homogeneity. Therefore, this method demonstrated the way leading to large 
production and purification of recombinant proteins. 
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2.5.3 Characterization of his-tag P30 
The his-tag P30 was a fusion protein. It consisted of the histidine-tagged tail 
(histidine tail) and P30 epitopes. The histidine tail was detected by monoclonal 
antibody of his-tag. The antibody was highly specific because only single band was 
detected in a protein mixture of bacterial lysate. In addition, as it recognized only six 
residues of histidine, it could detect histidine-tagged protein under deanture 
conditions and irrespective to the expression systems used. Besides, the histidine tail 
was evident by amino acid sequencing. 15 cycles of sequencing reactions were 
performed on his-tag P30 in which the amino acid sequence obtained from the 
experiment was completely matched with the expected sequence. The N terimus of 
the protein was not blocked. However, the background of the first few sequencing 
cycles was high. It was duo to the glycine which was a major component of 
transblotting buffer. Therefore, more sample was needed to compensate the 
background noise. On the other hand, another transblotting buffer without amino acid 
residues could be used. 
The protein sequence consisted of three important parts. First, it contained a 
methionine start codon. It was characteristic of recombinant protein produced by 
bacterial expression systems. The additional of methionine might cause the 
recombinant protein antigenic and resulted in undesirable effect. Therefore, it should 
be attention if the protein was applied in clinical uses. Second, the protein followed 
with six histidines. It provided a ligand for the attachment of heavy metal-containing 
resin and recognition of monoclonal antibody. Therefore, it was important for 
purification and detection. Finally, it contained part of the thrombin binding site. It 
provided a ligand for purification and could be cleaved off by specific proteases. 
In this experiment, enterokinase was used to cut the fusion tag because it 
retained minimal number of amino acid residues at N terimus of the recombinant 
protein. The denatured protein was first dialyzed before enterokinase digestion. The 
size of enterokinase-cut his-tag P30 was changed from 32 to 22 kDa. However, it was 
observed that the mobility of his-tag P30 in SDS-PAGE increased after dialysis (Burg 
et al., 1988). It suggested that dialysis aided refolding parts of the P30 structures. 
Refolded protein was more antigenic to seropositive sera of human (unpublished 
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observation of Dr. Chen). As seropositive serum contained more antibodies to 
recognize native P30, renaturation of his-tag P30 was promising for large-scale 
production of "antigenic" protein. 
The P30 epitopes of the protein could only be detected by seropositive 
(mouse, rabbit and human) but not seronegative sera. It was important if the protein 
was used as diagnostic agent of Toxoplasmosis. Furthermore, the P30 sequence in 
recombinant protein was obtained by amino acid sequencing on enoterokinase-cut his-
tag P30. 13 cycles of sequencing reactions were performed. All amino acids except 
cysteine were matched with expected sequence. It was because special pre-treatment 
of the protein sample was necessary to detect cysteine but this step had not been done 
in this experiment. In addition, from the protein sequence, an additional alanine was 
found. Antigenic effect of this additional alanine should be tested before using this 
protein as subunit vaccine. 
Antiserum was raised by immunizing mice with gel granules containing his-
tag P30. The SDS-PAGE gel not only denatured protein but also provided an adjuvant 
effect.. The antiserum was highly antigenic as it recognized his-tag P30 over a titer of 
1:8000 (data not shown) and used to probe with P30 on T. gondii lysate. A 35 kDa 
band on T. gondii lysate was detected. It represented P30 protein of T. gondii under 
reducing conditions (Burg et al” 1988). The ability to detect P30 on T. gondii implies 
the recombinant his-tag P30 contained B-cell epitopes of native P30. The presence B-
cell epitopes could also be demonstrated by immunofluescence study on fixed T. 
gondii. Because antibodies coated specifically on T. gondii surface (Godard et al., 
1994; Velge-Roussel et al., 1994). In addition, the T-cell response could also be 
checked as it was important in Toxoplasma infection. T-cells from immunized mice 
was taken out and stimulated to proliferate by addition of his-tag P30. More 
importantly, the his-tag P30 could be used as subunit vaccine such that challenge 
experiment of virulent tachyzoite could be performed on immunized mice (Petersen et 
al., 1998). 
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Chapter 3 Expression of P30 in Arabidopsis thaliana 
3.1 INTRODUCTION 
3.1.1 Why Arabidopsis thaliana ？ 
Arabidopsis thaliana is a flowering plant and an inconspicuous weed 
belonging to Brassicaceae. As it has some features that make it suitable for studies on 
classical plant as well as molecular genetics (Meyerowitz, 1989; Damm and Halfter, 
1993). Its small size, short generation time and ability to grow well in constant 
fluorescent light make indoor maintenance of large population of Arabidopsis plants 
inexpensive and easy. The large amount and small size of seed produced after 
pollination makes large-scale mutagenesis easy when exposed to many mutagens such 
as ethyl methanesulfonate (EMS). Therefore, many mutations have been identified, 
studied and mapped. Self pollination allows purification of homozygous transgenic 
plant with single insertion through mendelian segregation means while cross 
pollination allows combination of different transgenes to confer hybrid traits. 
The availiability of genetic and physical maps with multiple markers allow the 
location on mutated gene on chromsomes easily. The haploid genome consists of five 
chromosomes, approximately 70,000 kilobase pairs (kb) which is thus the smallest 
genome known for higher plants so far. The small genome together with very low 
level of dispersed repetitve DNA allows rapid and repetitive screening of genomic 
library with minimal effort. As several Arabidopsis genomes in lambda or cosmid 
library can be plated out in a single petri dish, a probe from known sequence can 
identify overlapping clones. Chromosome walking along overlapping cosmids can be 
mediated rapidly and easily. 
Simple and easy DNA-mediated transformation can be applied with 
Arabidopsis makes it successfully used to study factors involved in gene expression or 
function. Many different methods have been employed for transformation into 
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Arabidopsis genome. By T-tagging insertional mutagenesis, the biological function of 
numberous novel genes can be elucidated. 
3.1.2 In planta transformation 
Agrobacterium-mtdidXtd transformation has been demonstrated to be effective 
in transferring genes into plants. It has been widely used after a simple and convenient 
leaf-disk method was devised (Horsch et al., 1985). However, regeneration 
procedures usually require the transformed tissue to be in culture for a substantial 
period of time. The resulting cultures frequently exhibit a loss in morphogenetic 
potential. Besides, the regenerated plants often exhibit abnormal appearance or a loss 
of fertility�which may be duo to somatic mutations during regeneration in tissue 
culture conditions. Several non-tissue culture (so-called in planta) methods for 
transformation with Agrohacterium have been developed recently for Arabidopsis 
thaliana, but may be applicable to other species. 
The first non-tissue culture approach of agrobacterium-mediated 
transformation was applied to germinating seeds of Arabidopsis thaliana (Feldmann 
and Marks, 1987). Seed of Arabidopsis thaliana ecotype Columbia-0 was imbibed for 
12 hours before a 24 hours exposure to Agrobacterium inoculation. By plating the 
seeds on medium containing a selective agent, transgenic individuals were identified. 
Although mechanism of transformaton is unknown, reasonable transformed progenies 
were obtained by this method. 
As this method does not involve tissue culture for regeneration, it will not 
cause somatic mutations during the transformation process and is particularly useful 
for mutagenesis study. It has been applied for T-DNA tagging on Arabidopsis 
thaliana (Feldmann, 1991) and generated a lot of transgenic plants (Feldmann et al., 
1989). However, this method has proved to be rather difficult to reproduce beyond the 
Feldmann laboratory. 
The second method was developed by Chang's group (Chang et al., 1994). 
Stably transformed A. thaliana could be produced in only 7-8 weeks. When the 
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primary inflorescence shoots reached 1-2 cm in height, they were cut at their bases 
together with 2-3 upper rosette leaves. Freshly cultured A. tumefaciens strain bearing 
binary vectors was applied to the wounds with a pasteur pipette. On average, 5.5% of 
the newly regenerated shoots produced transformed progenies. More than 90% of the 
transformed progenies exhibited Mendelian segregation patterns of marker genes. Of 
those, 60% contained one functional insert (Katavic et al” 1994). This wounded plant 
transformation is a reliable and reproducible. 
Although methods target on germinating seed and wounded plant can 
transform A. thaliana successfully, transformants are selected at low frequency among 
the progenies of inoculated plant. From these methods, all the transgenic individuals 
are independent and hemizygous, the target cell for Agrobacterium transformation are 
likely to be zygote or the gametes. Therefore, it is expected to have higher 
transformation efficiency if plants are inoculated as late as possible. Whole plants, 
when the primary inflorescence is 10-15 cm high, the first siliques are formed and 
secondary inflorescences are appearing, are inoculated into a suspension of 
Agrobacterium and applied with vacuum. Following vacuum infiltration, the plants 
are returned to the greenhouse to produce seed. The transformants are selected under 
selective medium. This vacuum infiltration method is simple, reliable and fast 
because it does not involve regeneration of severed shoots by wounded plant method. 
Besides, no expert is needed to achieve successful transformation. More importantly, 
large amount of transformants can be obtained in a single plant or transformation 
event (Bechtold et al, 1993). 
In original method of vacuum infiltration, it involved the growth of 
Arabidopsis to flowering stage, uprooting of plants, application of Agrobacterium to 
whole plants via vacuum infiltration in a sucrose/hormone growth medium, re-
planting, collecting seed a few weeks later, and identification of transformed 
progenies in selection medium. These labor-intensive steps can be eliminated in a 
simplified approach called floral dip (Clough and Bent, 1998). It was found that 
simple dipping of developing floral tissues into a solution containing Agrobacterium 
tumefaciens, 5% sucrose and 0.005% surfactant Silwet L-77 for few seconds would 
allow efficient transformation comparable to original method of vacuum infiltration. 
The plant tissue culture media, hormone benzylamino purine and pH adjustment were 
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unnecessary for successful transformation. Surfactant and humidity were important as 
it reduced surface tension and greatly enhanced entry of bacteria into relatively non-
accessible plant tissues. 
3.1.3 Transgenic plants as vacine production systems 
Advances in cellular and molecular biology provide the opportunity to 
engineer plants to produce a wide variety of products such as using plants as green 
factories to produce pharmaceutical products (review by Ganz et al” 1996). One of 
the major attractions is production of antibody in plants (review by Ma and Hein, 
1995; Conrad and Fiedler, 1998). Plants are capable of synthesizing and assembling 
virtually every kind of antibody molecules. Production of secretory IgA against 
Streptococcus mutans prevents bacterial colonization on mouth cavity and dental 
caries in human (Ma et al., 1998). 
Besides, plant has been widely used for production of subunit vaccine (review 
by Moffat, 1995; Herbers and Sonnewald, 1999). The use of plants as bioreactors is of 
special interest as they allow production of recombinant proteins in large quantities at 
relatively low costs. In addition, formulated in seeds, plant-made proteins have been 
found to be extremely stable, reducing storage and shipping cost. Furthermore, 
production size is flexible and easily adjustable to the needs of the changing markets. 
It is free of human diseases and reduces the costs of purification. Immunization is 
possible simply through comsumption of an edible vaccine. Because it stimulates the 
mucosal immune system to produce secretory IgA at mucosal surfaces such as gut and 
respiratory epithelia. This is particularly useful for developing countries as it is cheap, 
stable, no need of costly fermentation-based production, flexible and immunization 
simply by consumption (Mason and Arntzen, 1995). 
There are currently two different strategies for transgene expression in plant. 
First strategy involves stable integration with foreign DNA into plant genome. The 
second strategy is transient expression of foreign gene product in plant by using plant 
viral vectors. 
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Stable expression has the advantage of subsequent generation of large number 
of transgenic plants and the opportunity to introduce more than one gene for multiple-
component vaccine production by crossing. While transient expression is rapid, 
technically easier and greater yields of foreign proteins can usually be recovered. The 
virus grows extremely well in host plants, yields reaching l-2g/kg of plant tissue, the 
virus is thermostable, and the purification of virus particles is straightforward. 
(a) Stable expression of E. coli heat-liable enterotoxin B subunit and cholera-
toxin B subunit 
Cholera is a devastating infectious diarrheal disease that has caused recurrent 
pandemics throughtout the developing worlds. The total number of annual cholera 
cases and death especially among children around global exceeds 5 million and 
200,000 repectively. Diarrhea-causing bacteria include Vibrio cholerae and related 
enterotoxigenic E. coli (ETEC). They colonize small intestine and produce one or 
more enterotoxins, including cholera-toxin (CT) from V. cholerae or heat-liable 
enterotoxin toxin (LT) from ETEC. CT and LT are structural, functional and 
antigenical similar to each other. 
By X-ray crystallography studies, LT was revealed as a multimeric protein and 
consisted of one A subunit (LT-A) and a pentamer of B subunit (LT-B). LT-B bound 
to GMl gangliosides on membranes of epithelial cells and then initiates transport of 
the active subunit LT-A into cells. Once LT-A entered cells, it initiated cellular 
metabolic changes that lead to loss of water from the cell. Interference of LT-B 
binding to GMl gangliosides by anti-LT-B antibodies was effective against diarrhea 
(Pedoussaut et al” 1989). 
Recombinant LT-B subunit was produced by transgenic tobacco and potato 
plants. It was immunogenic and caused serum and mucosal antibodies after oral 
adminstration in mice (Haq et al., 1995) and in human (Tacket et al., 1998). In 
addition, oral immunization of transgenic potato-derived CT-B could also protect 
mice from diarrhea (Arakawa et al” 1998). Therefore, both LT-B and CT-B could 
stimulate lymphoid tissues of gut and were useful adjuvant for immunization. 
73 
Type I diabetes or insulin-dependent diabetes mellitus (IDDM) was thought to 
be an autoimmune disease in humans. The disease might be caused by the 
lymphocytic infiltration to the islets of Langerhans and resulted in destruction of 
insulin-producing beta cells. It was found that nonobese diabetic (NOD) mouse 
spontaneously developed an autoimmune form of diabetes and was used as mouse 
model of IDDM. Immunization of autoimmune antigens such as glutamic acid 
decarboxylase (GAD) and insulin into NOD mice could suppress diabetes (Zhang et 
al, 1991). Transgenic plants expressing GAD could induce oral immune tolerance 
and inhibit development of diabetes in NOD mice (Ma et al., 1997). Besides, oral 
adminstration of CT-B-insulin fusion produced from transgenic potato could also 
protect against the development of IDDM in NOD mice (Arakawa et al., 1998b). 
(b) Stable expression of Hepatitis B surface antigen (HBsAg) 
It was estimated that about 300 million carriers of hepatitis B vims (HBV) 
infection in the world. The worldwide problem of HBV infection and its association 
with chronic liver disease has necessitated the development of an effective vaccine. 
Because HBV cannot be propagated in tissue culture and has limited host range, first 
vaccine was obtained from purification of human blood. Later, recombinant subunit 
vaccine for HBV was commercially developed from yeast and put into market as first 
recombinant subunit vaccine. As yeast-derived vaccine required expensive 
fermentation-based production and downstream processing, the expense of 
immunization was prohibitive. 
Tobacco plants were genetically transformed with the gene encoding hepatitis 
B surface antigen (HBsAg) linked to a modified CaMV 35S promoter (Mason et al., 
1992). Expression level of HBsAg derived from plant was 0.01%. The HBsAg was 
virtually indistinguishable from serum-derived and yeast-derived HBsAg with repect 
to size, density sedimentation and antibody binding. In addition, the immunogenic 
properties of this HBsAg were also tested. The anti-hepatitis B response to the 
tobacco-derived HBsAg was qualitatively similar to that obtained by immunizing 
mice with yeast-derived HBsAg. Additionally, the T cells obtained from mice primed 
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with the tobacco-derived HBsAg could be stimulated to proliferate in response to 
antigenic determinants of HBsAg (Thanavala et al., 1995). 
(c) Stable expression of Norwalk virus capsid protein 
Norwalk virus (NV) is a member of the Caliciviridae family and causes 
epidemic of acute gastroenteritis in humans. NVCP gene was engineered into tobacco 
and potato tuber. The expression level was 0.23% of the total soluble protein. The 
plant-derived NVCP could self-assemble and showed antigenically similar to insect 
cell-derived NVCP. Oral adminstration of plant-derived NVCP into CDl mice could 
trigger both serum IgG and secretory IgA for NV (Mason et al., 1996). 
(d) Transient expression by tobacco mosaic virus 
The self-assembling properties of the tobacco mosaic vims (TMV) coat 
protein was used to produce subunit vaccine. By X-ray crystallography studies, it was 
revealed that TMV contained at least four distinct regions of TMV coat protein and 
two of which were used in epitope fusion. Several sporozoites epitopes of 
Plasmodium were selected and inserted into the surface loop region of the TMV coat 
protein or fused to C terminus. The plant-derived malaria epitopes could react with 
sporozoite-specific monoclonal antibodies. 
The glycoprotein (G) of rabies virus had been identified as a major antigen to 
induce protective immunity against rabies vims. Virus-neutralizing antibodies (VNA) 
induced solely by G protein was believed to play a major role in immuno-protection 
against rabies. Two linear epitopes of G protein of rabies virus were found and 
showed to induce protective immunity against lethal rabies virus challenge 
(Dietzschold et al, 1990). Expression of these epitopes on TMV virus could produce 
immunogenic form and raise VNA in mice (Yusibov et al, 1997). Intraperitioneal 
immunization of these plant-derived antigens could protect 40% of mice against 
challenge infection with a lethal dose of rabies virus. While oral administration could 
ameliorate the clinical signs of the disease in mice (Modelska et al.，1998). 
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(e) Transient expression by Cowpea mosaic virus capsid protein fusion 
Although it has been demonstrated that synthetic oligopeptides are capable of 
stimulating the production of antibodies against the protein from which they are 
derived, they are not usually as immunogenic as expected. An epitope-presentation 
system has been devised in which the peptide sequence is biochemically fused to a 
capsid molecule of a virion, to overcome the problem (Porta et al” 1994). Cowpea 
mosaic virus (CPMV) can be adapted to express a foreign epitope. 
By this method, several epitopes, from foot-and mouth disease virus (Usha et 
al., 1993)，human rhinovirus 14 (HRV-14) and immunodeficiency vims type 1 (HIV-
1) (Porta et al., 1994) have been expressed together with its fusion coat protein 
partner. The chimeric vimse particules of HRV-14 have been demonstrated to possess 
antigenic properties and shown immunogenic in rabbits. Antisera to CPMV-HIV 
chimera was able to neutralize three different strains of HIV-1. 
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3.2 MATERIALS 
3.2.2 Bacterial Strains 
Agrobacterium tumefacien, GV3101/pMP90 
3.2.3 Arabidopsis strains 
Arabidopsis thaliana ecotype Columbia-0 
3.2.4 Chemicals 
1. Benzylaminopurine Sigma B5898 
2. Boric acid Sigma B0252 
3. Calcium nitrate Ajax 135 
4. Cetyldimethylethylammonium bromide (CTAB) Sigma C5335 
5. Chloroform Ajax 152 
6. Cupper sulfate, anhydrate Sigma C1297 
7. Cupric chloride, dihydrate Sigma C6641 
8. Diethyl pyrocarbonate Sigma D5758 
9. Dithiothreitol, DDT (lOOmM) Promega PI 171 
10. EDTA, disodium salt Pharmacia 17-1324-01 
11. Formaldehyde (37%) Merck 104000.025 
12. Formamide Gibco 15515-026 
13. Genetamicin sulfate Sigma G3632 
14. Iso-amylalcohol Ajax 64 
15. Isopropanol Labscan C2519 
16. Lithium chloride Sigma L8895 
17. Magnesium chloride Sigma M9272 
18. Manganese chloride Sigma M3634 
19. Metro-mix soil Hummert 10-0325 
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20. MES B/M 223794 
21. MOPS Sigma M8899 
22. Murashige and Skoog micronutrient salt Gibco 11155-025 
23. Nicotine acid Sigma N4126 
24. N-lauroylsarcosine Sigma L5125 
25. Phenol-chloroform-isoamylalcohol (25:24:1) Amersco 883 
26. Potassium acetate Sigma PI 147 
27. Potassium nitrate Sigma P8394 
28. Potassium phosphate, monobasic Sigma P5379 
29. Pyridoxine-HCl BDH 44086 
30. Rifampicin Sigma R3501 
31. Sodium acetate, anhydrous Sigma S2889 
32. Sodium citrate, trisodium salt Sigma S4641 
33. Sodium molybdate-2-hydrate RDH 31439 
34. Silwet L-77 LEHLE SEEDS VIS-01 
35. Sucrose Sigma S1888 
36. Thiamine-HCl Sigma T4625 
37. Tween 20 Biorad 170-6531 
38. Zinc sulfate, heptahydrate Sigma Z4750 
3.2.5 Nucleic acids 
1. Oligo dTi2-i8 Pharmacia 27-7858-01 
2. V7 plant expression vector From Dr. Lam 
3.2.6 Kits and Reagents 
Qiagen plasmid midi kit Qiagenl2143 
DIG DNA labelling and detection kit Boehringer Mannheim 1093657 
Nylon membrane, positively charged Boehringer Mannheim 1209299 
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3.2.7 Solutions 
1. 20x SSC 3M NaCl, 300mM sodium citrate, pH 7.0 
2. Washing solution 2x 2x SSC, 0.1% SDS 
3. Washing solution 0.5x SSC, 0.1% SDS 
0.5x 
4. N-lauroylsarcosine 10% (w/v) in sterile H2O 
filtered through a 0.2^im membrane 
5. SDS 10% (w/v) in sterile H2O 
filtered through a 0.2jim membrane 
6. DEPC-treated H20 Dissolve DEPC to 1% in ultrapure H20 and keep overnight 
Autoclave to remove residual DEPC. 
7. lOx MOPS 200mM MOPS, 50mM sodium acetate�lOmM EDTA, pH 
7.0. Make up in sterile H2O. After autoclaving, the solution 
will turn yellow. 
8. RNA loading buffer 250^il formamide, 83^il formaldehyde 37% (w/v), 50^il lOx 
MOPS buffer, 0.01% (w/v) bromophenol blue, SOjil glycerol. 
Fill up to 500|il with DEPC-treated H2O. 
9. Maleic acid buffer O.IM maleic acid, 0.15M NaCl, pH 7.5. Adjust pH with 
concentrated NaOH; autoclave. 
10. Washing buffer Add 0.3% (w/v) Tween 20 to maleic acid buffer 
11. Blocking reagent Add lOg blocking reagent to 100ml maleic acid buffer with 
stock solution several 30s heat pulses in the microwave. 
12. Blocking buffer Dilute blocking reagent stock solution 1:10 with maleic acid 
buffer 
13. Detection buffer lOOmM Tris-HCl, pH 9.5 and lOOmM NaCl 
14. Color substrate Freshly prepare 
solution 45^1 NBT solution and 35\xl BCIP solution are added to 
10ml detection buffer. 
15. Dupurination solution 0.25M H Q 
16. Neutralization 0.5M Tris-HCl，pH 7.5 and 3M NaCl 
solution 
17. Standard 5x SSC, 0.1% N-lauroylsarcosine, 0.02% SDS, 1% blocking 
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hybridization buffer reagent 
(southern blot) 
18. High SDS 7% SDS, 50% formamide, 5x SSC, 2% blocking reagent, 
concentration 50mM sodium-phosphate, pH 7.0 and 0.1% N-
hybridization buffer lauroylsarcosine 
(northern blot) 
19. PI buffer 50mM Tris-HCl, pH 8.0, lOmM EDTA and lOOjiig / ml 
Rnase A 
20. P2 buffer 200mM NaOH, 1% SDS 
21. P3 buffer 3M potassium acetate, pH 5.5 
22. QBT buffer 750mM NaCl, 50mM MOPS, pH 7.0 and 15% ethanol 
23. QC buffer IM NaCl, 50mM MOPS, pH 7.0，15% ethanol 
24. QF buffer 1.25M NaCl, 50mM Tris-HCl, pH 8.5，15% ethanol 
25. TioEi lOmM Tris-HCl, pH 8.0 and ImM EDTA 
26. TioEo.i lOmM Tris-HCl, pH 8.0 and O.lmM EDTA 
27. YEP meidum lOg tryptone, lOg yeast extract and 5g NaCl. Fill up with 1 
litre with H2O 
28. lOOOx B5 vitamine lOOOmg myo-inositol�lOOmg thiamine-HCl, lOmg nicotine 
acid, lOmy pyridoxine-HCl. Fill up to 10ml with H2O 
29. Arabidopsis 70ml 0.5M boric acid�14ml 0.5M MnCl2�2.5ml IM CUSO4, 
micronutrients 1ml O.IM NaMo04,1ml 5M NaCl, and 0.05ml O.IM CuCl�. 
Fill up to 500ml with H2O. 
30. lOx Arabidopsis 50ml IM KNO3, 25ml IM KPO4 (pH 5.5), 20ml IM MgSCU, 
fertilizer 20ml IM Ca(N03)2, 5ml O.IM FeEDTA and 10ml 
micronutrients. Fill up to 1 litre with H2O 
31. Infiltration medium 2.2g MS salts, Ix B5 vitamins, 50g sucrose, 0.5g MES and 
200jil SilwetTM L-77. Adjust pH to 5.7 with KOH and fill up 
to 1 litre solution. Autoclave. 
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3.2.8 Enzymes and buffers 
1. M-MLV reverse transcriptase Gibco BRL 28025-013 
2. 5x M-MLV RT buffer Gibco BRL 28025-013 
3. RNase One™ ribonuclease Pharmacia 27-7858-01 
4. rRNase ribonuclease inhibitor Promega M4261 
5. ThermoprimePlus DNA polymerase Advanced Biotechnologies 
#AB0310 
6. lOx PCR buffer and 25mM MgCl2 Advanced Biotechnologies 
#AB0310 
3.2.9 Sequencing Primers 
Name of primer Sequence (5’ to 3，） 
V7 promoter sequencing p r i m e r T C C AAC CAC GTC TTC AAA GC 
MF 457 GGT CGT CAA TAA TGT CGC AAG G 
MF458 TAA TGA CGC TTT TTG ACT CGG CT 
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3.3 METHODS 
3.3.1 Construction of V7-ASP30API 
A plant expression vector was obtained from Dr. Lam. It contained a strong 
and constitutive promoter derived from Cauliflower mosaic virus 35S ribosomal RNA 
(CaMV S35) and selectable marker conferring kanamycin resistant phenotype 
(neomycin phosphotransferase II，NPTII). It contained a multiple cloning site with 
different restriction sites shown in Figure 3.1. 
Plant constitutive expression vector (V7 or pTEV 8) 
RB 
Sail Ecol Ecol Smal 
I 1 NPT ~ | 1 TER I — ； ^ 令 CaMV 35S ~ | 
Xhol-BamHI-Xbal-Hindlll 
Figure 3.1 Schematic diagram of y ? vector. V7 is a plant constitutive 
expression vector with strong promoter derived from Cauliflower mosaic virus 35S 
ribosomal RNA (CaMV 35S). Following the promoter, there is a multiple cloning site 
containing several restriction recognitioin sites and a nospaline terminator for a 
polyadenylation signal. In addition, there is a neomycin phosphotransferase as 
selectable marker as it can inactivate antibiotic kanamycin by phosphoralation. 
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Ifxg of V7 plasmid in 14\il distilled H2O was used to transform DH5a 
competent cell. V7 plasmid was isolated and quantitated. of V7 vector and pET-
ASP30API prepared in 3.3.1(a) were restriction digested by 8 units of Xbal and Xhol 
in 40pil final volume of Ix One-Phor-All buffer at 3TC for 2 hours. The Xbal-Xhol-
cut V7 and smaller-sized insert of pET-ASP30API bands were excised, purified by 
and finally eluted into 60|il distilled H2O. 
5\il eluted DNA of Xbal-XhoI-cut V7 and lOjxl eluted DNA of pET-
ASP30API was ligated. 15^1 of ligation mix was used to transform DH5a competent 
cell. Putative plasmid V7-ASP30API was prepared to perform cycle sequencing 
reaction. 2\xg of putative V7-ASP30API was mixed with Ijil of 3.2 pmole V7 
promoter specific primer for sequencing reaction. All the procedures performed 
according to the procedures described in 2.3.1(a). 
3.3.2 Agrobacterium-mediated transformation of Arabidopsis by vacuum 
infiltration 
(a) Preparation of electro-competent agraobacterium 
Single colony of agrobacteria strain, GV3101/pMP90, was obtained from Dr. 
Lam. It was picked and inoculated into 10ml LB+Rif 50+Genta 25 broth. It was 
shaken vigorously at 28°C for 2 days until a dense culture with the optical density at 
600nm over 2. 8ml of dense culture as starter was added to 400ml pre-wanned 
LB+Rif 50+Genta 25 broth. The culture was shaken vigorously at 28°C until the 
optical density was between 0.5 to 1. The bacterial culture was then chilled on ice for 
15 minutes. The cells were harvested by centrifugation at 4,000 x g for 15 minutes at 
4°C. The pellet was washed twice in respective 400ml and 200ml ice cold autoclaved 
H2O with the same centrifugation conditions. The washed pellet was resuspended in 
4ml of pre-chilled 10% glycerol. It was transferred to 15ml centrifuge tube and spun 
again with same conditions. Finally the pellet was resuspended in 0.4ml pre-chilled 
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10% glycerol. It was divided into 40(il aliquots and stored at -70°C as stock of 
electro-competent cell. 
(b) Transformation of electro-competent agrobacterium with V7-ASP30API by 
electroporation 
An aliqout of electro-competent agrobacteria was thawed on ice and mixed 
with lOOng of V7-ASP30API plasmid. It was incubated on ice for 1 minute and 
transferred to a pre-chilled electroporation cuvette carefully without introducing any 
bubbles. The cuvette was wrapped with absorbent paper to ensure no water condensed 
on its surface. It was then inserted into sample position of gene pulser apparatus 
(BioRad) where it was set with conditions: 25!iF, 2.5kV and 600 ohms. An electrical 
pulse was applied. 
1ml SOC medium was added to resuspend the cells in cuvette. The cell 
suspension was transferred to a 17x100mm polypropylene tube and shaken at 28°C 
for 2 hours. 50\il of the culture was spreaded on LB+Rif 50+Genta 25+Kan 50 plate. 
It was incubated at 28°C for 2 days to develop transformed agrobacterial colonies 
containing V7-ASP30APL 
(c) Plasmid preparation of V7-ASP30API from transformed agrobacteria 
Since the copy number of V7-ASP30API plasmid in agrobacteria was low, it 
was purified by special protocol of QIAGEN plasmid purification system. A single 
colony of transformed agrobacterium was picked and inoculated into 15ml YEP+Rif 
50+Genta 25+Kan 50 medium. It was shaken overnight at 28°C. 2ml of the overnight 
culture as starter culture was added to 200ml pre-warmed YEP+Rif 50+Genta 
25+Kan 50 medium and shaken at 28°C overnight. Cells from overnight culture were 
harvested by centrifugation at 6,000 rpm at 4°C for 20 minutes (JA-20 rotor, 
Beckman). 
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The bacterial pellet was resuspended in 20ml PI solution and then transferred 
to 200ml sterile centrifuge bottle. 20ml P2 solution was mixed with the cell 
suspension gently. It was incubated at room temperature for 5 minutes. 20ml pre-
chilled P3 solution was mixed with the cloudy suspension thoroughly but gently by 
inverting. The bacterial lysate was kept on ice for 30 minutes before centrifugation. It 
was spun at 12,000 rpm at for 30 minutes (JA-20 rotor, Beckman). Supernatant 
was transferred to new 200ml centrifuge bottle and spun again with same condition. 
35ml (0.7 volume) of the isopropanol was mixed with the clarified lysate to 
precipitate plasmid DNA. It was then spun at 10,000 rpm at 4°C for 30. Supernatant 
was taken out carefully and discarded. 
The DNA pellet was dissolved in SOOfxl TioEo.i and added with 4ml QBT 
buffer. The QIAGEN column was pre-equilibrated with QBT and loaded with sample. 
The column was drained until no more drops. The column was washed twice with 
10ml QC washing buffer. Resin-bound plasmid DNA was eluted with 5ml pre-warm 
QF elution buffer. The elutent was collected into a 30ml Corox tube and added with 
3.5ml isopropanol to precipitate DNA. The precipitated DNA was pelleted by 
centrifugation at 12,000 rpm, at 4°C for 30 minutes and then dried by vacuum 
centrifuge for 10 minutes. Dried DNA pellet was dissolved in 20|il TioEo.i-
5\il V7-ASP30API plasmid was restriction digested by 4 units of Xbal and 
Xhol in 20\il final volume of Ix One-Phor-All buffer at 37°C for 2 hours. Similarly, 
l^ig of V7-ASP30API prepared from DH5a was digested with same condition as size 
marker of the Xbal-XhoI-cut insert of V7-ASP30API. lO^il of the digestion mixes 
were loaded into 1% agarose gel, resolved by electrophoresis and visualized by UV 
illumination. 
(d) Vacuum Infiltraion 
Arabidopsis ecotype Columbia-0 seeds obtained from Dr. Lam were kept at 
4°C for at least 2 days as imbibition period to sychronize germination. It was then 
sowed on wet Metro-Mix soil and allowed to grow on plastic pot. It was placed in 
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growth chamber with addition of Ix arabidposis fertilizer per week. In growth 
chamber, the condition was set: temperature was 22�C while the light-dark cycle was 
16 hours light (daylight, 4000k lux) and 8 hours dark. After 4 to 6 weeks, plants at 
flowering stage were ready for agrobacterium-mediated transformation. 
500ml dense culture of transformed agrobacteria containing V7-ASP30API in 
YEP+Rif 50+Genta 25+Kan 50 medium was prepared following procedures described 
in 3.3.2(c). The cells were harvested by centrifugation of 6,000 rpm at 4°C for 20 
minutes (JA-20 rotor, Beckman). The bacterial pellet was resuspended in 1 litre of 
infiltration medium. The suspended culture was transferred into a beaker inside a 
vacuum desiccator. 
Plants in pot were inverted and immersed into bacterial suspension. The entire 
plants should be covered within medium to ensure successful transformation. Vacuum 
at about 400mm Hg was applied for 15 minutes. These infiltrated plants were taken 
out and dried. It was set upright by plastic rolls and put into growth chamber under 
same conditions as before. Infiltrated mature plants were stopped watering for 4-6 
weeks. Seeds were harvested individually and designated as the number of plant. 
3.3.3 Screening of homozygous transgenic plants 
lOO i^l of seeds from each individual plant (FO) was put into 1.5ml sterile 
eppendorf tube and sterilized under laminar hood. It was added with 1ml Chorox and 
vortexed for 3 minutes. They were spun down by brief centrifugation and further 
washed 3 times of 1ml sterile H2O. The sterilized seeds were then spread into 
MS+Kan 50 plate. These plates were placed under growth chamber at defined 
conditions. Green transformants (Fl) were selected and allowed to grow and self-
cross. 
Seeds from mature Fl were harvested individually and sterilized. They were 
plated on new MS+Kan 50 plate in array order and placed under growth chamber at 
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defined conditions for 2 weeks. Amount of green transformant (F2) and yellow 
plantlets were counted for chi-square analysis. Green transformants (F2) with 
acceptable chi-square values were selected and grown on new MS+Kan 50 square 
plates at tile position relative to light source, which allowed developing longer root 
and reduced damages during uprooting. After 3 weeks, they were transferred to plastic 
pots with wet Metro-Mix soil and allowed to self-cross. Seeds from F2 plants were 
harvested and allowed to develope into homozygous transgenic plants (F3). 
3.3.4 Detecton of transgene P30 in genomic DNA of transgenic plants 
(a) Preparation of DIG-labelled probe 
40^g of pET-ASP30API prepared in 2.3.1(h) was restriction digested by 60 
units of Xbal and Xhol in final volume of 140^il Ix One-Phor-All buffer at 37°C 
overnight. All digestion mix was loaded on 1% agarose gel for electrophoresis. The 
restriction fragment representing ASP30API was excised, purified and eluted into 
ISO i^l distilled H2O described in 2.3.1. ISOyd of the eluted fragment was added with 
ISyd of hexanucleotide mixture, IS^il dNTP labelling mixture, 3^ x1 Klenow enzyme 
and 4^1 distilled H2O for DIG labelling reaction. It was incubated at 3TC overnight. 
The labelling reaction was stopped by addition of 9^1 0.2M EDTA. 
lO^il 3M LiCl (0.1 volume) and 300fxl absolute ethanol were then added to 
labelling reaction for precipitation of DIG-labelled probe. It was incubated at -70°C 
for 20 minutes and then spun at 14,000 rpm for 30 minutes at 4°C. The supernatant 
was carefully pipetted out and discarded. The pellet was then washed with 200^ x1 pre-
chilled 70% ethanol. The washed pellet was dried by vacuum centrifuge for 10 
minutes. 200^1 TioEo.i was added to resuspend the dried pellet. 
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(b) Estimation the yield of DIG-labelled probe 
The yield of probe was estimeated by comparison of the DIG-labelled sample 
and DIG-labelled control. The DIG-labelled control DNA was diluted with DNA 
dilution buffer such that six different concentrations (5rig/^l，0.5Yig/|il, 50pg/fxl， 
5pg/\i\ and O.Spg/iil) were made. The concentration DIG-labelled probe was assumed 
to be 20rig/^il and therefore, it was diluted with DNA dilution buffer to make six 
concentrations same as that of DIG-labelled control. 
2|a1 of the prediluted solutions at different concentrations was dotted on 
membrane in array order. It was dried at room temperature and crosslinked by C4 
program of UV crosslinker (BioRad). Detection of DIG-labelled reagent was carried 
out at room temperature. The membrane was rinsed with washing buffer and then 
incubated in blocking solution for 30 minutes. The blocked membrane was then 
incubated with titer 1 : 5,000 of anti-DIG-alkaline conjugated with phosphatase 
antibody in blocking solution for 30 minutes. It was then washed with washing buffer 
for 2 X 15 minutes. After washing, it was incubated with detection buffer for 2 
minutes for equilibration and incubated into 10ml detection buffer with 45|il NBT 
solution and 35\i\ BCIP solution in dark for 30 minutes. Color spots would be 
developed in the membrane, which was then washed extensively with water and dried. 
Spot intensities of the control and experimental dilutions were compared to estimate 
the concentration of the experimental probe. 
(c) Extraction of genomic DNA from transgenic plants 
Fresh plant tissue was frozen by liquid nitrogen and ground into powder by a 
sterile pre-chilled mortar and pestle. The powder was transferred into 50ml falcon 
tube containing 15ml preheated CTAB extraction buffer. It was swirled gently and 
then incubated at 60°C for 30 minutes with occasional swirling. The plant lysate was 
mixed gently with 15ml choroform-isoamyl alcohol (24:1, v:v). The mixture was then 
centrifuged at 1,600 x g in a swinging bucket rotor (Beckman) at room temperature 
for 10 minutes. The upper aqueous phase was taken out by clean glass pipet and 
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transferred to sterile 50ml falcon tube. The aqueous solution was mixed with 10ml 
cold isopropanol gently and spun at 1,600 x g at 4°C to precipitate the nucleic acids. 
The DNA pellet was washed with 10ml 70% ethanol and spun again at 1,600 x g for 
10 minutes. The supernatant was poured off carefully and discarded while the pellet 
was dried by vacuum centrifuge for 10 minutes. The dried pellet was dissolved in 300 
TioEo.i by incubating at A^ 'C overnight and transferred to sterile eppendorf tube. It was 
spun at maximum speed for 5 minutes to remove any insoluble debris. The clear 
supernatant was transferred. RNase One was added to final concentration of O.lU/ul. 
The quantity of DNA in the sample was estimated by spectrophotometric 
measurement at OD26o. 
(d) Restriction digestion of genomic DNA with EcoRI and Hindlll 
25 ^ ig of genomic DNA was restriction digested with 50 units of EcoRI or 
Hindlll separately in final volume 50^il of 2x or Ix One-Phor-All buffer respectively 
at 37°C overnight. 32fil (i.e. 16|ig) digestion mix was loaded into 1% agarose gel for 
electrophoresis. A voltage of 5V per centimeter of the gel was applied for 3 hours at 
room temperature. The gel was stained with ethdium bromide and visualized under 
UV illumination. 
(e) DNA transfer from gel to nylon membrane 
Unused areas of the gel were cut off with a clean blade. The gel was 
depurinated in 250mM HCl for 10 minutes. It was submerged into denaturation 
solution for 2 x 15 minutes and subsequent neutralization solution for 2 x 15 minutes 
with shaking at room temperature. 
The nylon membrane was cut corresponding to the size of the gel. The blotting 
apparatus was assembled. The DNA from the gel was blotted to the membrane using 
20x SSC buffer. Air bubbles between gel and membrane or 3MM paper was removed 
by rolling a clean pipette over the surfaces. The transfer was carried at room 
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temperature overnight. The set-up was then disassembled. The membrane was rinsed 
with 2x SSC solution, air-dried and crosslinked. 
(f) Detection of hybridized DIG-labelled probe on membrane/ blot 
The blot was put into a clean hybridization tube filled with 20ml 
prehybrization buffer, and pre-hybridized at 68�C with constant rotation in a 
hybridization oven (Robbins Scientific Co” Model 1000) for 4 hours. lOOng DIG-
labelled probe corresponding was boiled for 10 minutes and kept on. Denatured DIG-
labelled probe was subsequently added to hybridization solution to a final 
concentration of lOng/ml. Hybridization was carried out at 68°C for 16 hours with 
constant rotation. The membrane was firstly washed twice with 2 x SSC, 0.1% SDS 
solution at room temperature to remove unbound probe. Then it was washed twice 
with 0.5 X SSC for 15 minutes at 68�C to remove nonspecifically bound probe. 
The hybridized probe was detected using DIG luminescent detection kit. All 
steps were performed at room temperature with constant rotation. After hybridization 
and post-hybridization washes, the membrane was equilibrated in washing buffer for 
1 minute and then incubated with 20ml blocking solution with constant rotation for 30 
minutes. The blocking solution was poured off and the membrane was hybridized 
with 20ml antibody solution for 30 minutes. It was prepared by adding 1: 10,000 titer 
of anti-DIG antibody conjugated alkaline phosphatase in blocking solution. The 
membrane was washed again with 2 x 15 minutes with washing buffer. It was then 
equilibrated with detection buffer for 2 minutes and reacted with fluorescent substrate 
CSPD by single-filter method. It was kept for 5 minutes at room temperature in 
between two sheets of plastic page protectors filled with 2ml of CSPD solution, which 
was prepared by adding CSPD at 1: 100 dilution to the detection buffer. It was then 
placed in between Saran wrap and incubated at 37°C for 15 minutes for accelerated 
reaction. The signal of fluorescent was recorded by X ray films. 
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(g) PCR on genomic DNA of transgenic plants with specific primers 
Genomic DNA of three homozygous transgenic (#2, #3 and #5) and control 
(V7) plants were used. Specific primer pairs (MF 457 and MF 458) were designed 
based on the coding sequence of P30 gene and used to detect P30 gene by PCR. 5fxg 
of genomic DNA of each sample was amplified in a 50jil PCR reaction containing 
0.5pmole of each MF 457 and MF 458, Ix PCR buffer, 1.5 mM MgCb, 0.2mM of 
each dNTPs, 0.5U Thermoprime^^^^ DNA polymerase. The PCR mixes were subject 
to repeated thermal cycles. The thermal cycle profile was: denaturation at 94°C for 30 
seconds, annealing for 30 seconds at temperature from 66 to 61°C with reduction of 
per cycle, and extension at 72°C for 1 minute. Total 25 PCR cycles were 
performed. 15fil of PCR products from each sample were loaded into 1% agarose gel 
for electrophoresis and visualized under ethiduium bromide staining. 
3.3.5 Analysis of transgene RNA expression in transgenic plants 
(a) Extraction of total RNA from plants 
Plant tissue was frozen by liquid nitrogen and ground into powder by pre-
chilled mortor and pestle. It was transferred to 50ml falcon tube and subject to RNA 
extraction and centrifugation. The conditions of centrifugation was 4,700 rpm, 5 
minutes at 4°C (Beckman) unless specified. 5ml of extraction buffer and 5ml of 
Phenol-Chloroform-isoamylalcohol (25:24:1) PCI was added to plant powder. It was 
vortexed vigorously for about one minute and spun. The upper aqueous layer was 
transferred into new 50ml falcon tube by baked glass pipet, mixed with 5ml new PCI 
and spun again. The upper clear aqueous layer was then mixed with one volume of 
Chloroform-isoamylalcohol (24:1), CI twice to remove any residual phenol. 
The upper aqueous layer was transferred to 50ml falcon tube. It was added 
with 1/10 volume of DEPC-treated 3M sodium acetate (pH 5.2) and 2 volumes of 
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absolute ethanol for precipitation of nucleic acids. The mixture was incubated at -
7(f C for 20 minutes and then spun. The pellet containing RNA was resuspended in 
1ml of DEPC-treated 3M sodium acetate (pH 5.6). The resuspended cloudy solution 
was transferred to sterilized 1.5ml eppendorf tube and spun at 14,000 x g for 10 
minutes at 4°C. The supernatant representing the DNA fraction was saved. The pellet 
was resuspended in 400|il of DEPC-treated 0.3M sodium acetate (pH 5.6) and 1ml 
absolute ethanol. The mixture was again kept at —TCfC for 20 minutes to facilitate 
precipitation RNA. The mixture was then spun at 14,000 x g for 20 minutes at 4°C. 
The RNA pellet was dried under vacuum centrifuge and resuspended into lOOfxl 
DEPC-treated H.O. The amount of RNA was estimated by UV spectrophotometric 
measurement in which 1 absorbance unit at 260nm representing 40fxg of RNA in 1ml 
solution. 
(b) Northern blot on RNA of F2 transgenic plants 
1 g of agarose was mixed with 87ml H2O and heated by microwave for 
melting and kept at 60°C. It was added with 10ml lOx MOPS and 3ml formaldehyde 
(37%). The denaturing gel solution was mixed well and casted in clean gel tray. 20\ig 
of each RNA sample was mixed in 50^il solution having 5\il of lOx MOPS, 25|il 
Formamide, 8.76!il Formaldehyde (37%), Ifxl ethdium bromide (Img/ml) and IjLil 6x 
loading buffer. The RNA mixture was heated at 55�C for 20 minutes for denaturation 
and then put into ice. The denatured RNA samples were loaded into denaturing 
agarose gel for electrophoresis with Ix MOPS as electrophoresis buffer. lOOV 
constant voltage was applied for about 3 hours to resolve RNA. 
The RNA on gel was transferred onto a nylon membrane using 20x SSC and 
crosslinked. The blot was blocked with high SDS prehybridization buffer which 
contained 50% formamide, 7% SDS, 5x SSC, 2% blocking solution and 50mM 
sodium phosphate (pH 7.0) for 4 hours at 68�C. The denatured DIG-labelled P30 
probe prepared in 3.3.4.b was added to high SDS prehybridization buffer to 25!Ag/ml 
for hybridization at 42°C overnight. The blot was washed and signals of P30 transcript 
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was detected by anti-DIG-AP antibody and CSPD chemiluminescent detection 
procedures as already described in 3.3.4. 
(c) RT-PCR on RNA of F3 transgenic plants 
2\ig of RNA sample was added with 1 unit of DNase I in 20^ x1 of Ix DNase I 
reaction buffer (Promega). The digestion mix was incubated at 37°C for 10 minutes 
for digestion and heated at 70�C for 10 minutes. The mixture was then chilled on ice 
immediately such that the RNA maintained at denatured state. 10^ x1 mixture was 
added to 40U RNase inhibitor, 0.1 jig oligo dTu-is, 0.5mM dNTP mixture, 1 x reverse 
transcription buffer, lOmM DTT and 200U Molony murine leukemia vims (M-MLV) 
reverse transcriptase in 20\i\ reaction volume. Another lOjil mixture was added with 
same reagents except no M-MLV reverse transcriptase. They was incubated at 37°C 
for 90 minutes for reverse transcription. 2\i\ of reverse transcription solution was 
amplified by PGR in 50\x\ PGR reaction. Total 35 cycles were performed and the 15fxl 
PGR products were loaded into 1.5% agarose gel for electrophoresis and visualized 
under UV illumination. 
3.3.6 Detection of his-tag P30 protein in transgenic plants 
The mature F3 plants were analyzed. They were frozen in liquid nitrogen and 
ground into powder as small as possible by a sterile pre-chilled mortor and pestle. 
2.5ml of protein extraction buffers at different pH (pH 5 and 7) was added per gram 
of plant tissue. The plant extracts were vortexed vigorously and then spun at 10,000 
rpm at 4°C for 15 minutes (JA-20 rotor, Beckmen). The supernatant was collected and 
frozen in 1ml aliquots. SOO^ il plant extract was mixed with 200^1 5x SDS-gel sample 
buffer with or without |3-mecaptoethanol and boiled for 8 minutes. 20\i\ of the 
samples were loaded into 12% SDS-PAGE for electrophoresis described in 2.3.2 (b). 
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Sample treated with P-mecaptoethanol was transferred to PVDF membrane. 
The western blot was performed with 1:500 titer of seropositive serum of human. 
Then they were incubated in antibody solution for 1 hour at room temperature. It was 
prepared by adding 4ml of 5% BLOTTO with 1:1000 titer of polyvalent anti-human 
Ig conjugated alkaline phosphatase. The membrane was washed again and incubated 
with NBT and BCIP for color development following procedures described at 2.3.2. 
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3.4 RESULTS 
3.4.1 Construction of V7-ASP30API 
The his-tag P30 fusion gene was retrieved from pET-ASP30API by Xbal and 
Xhol digestion and then subcloned into plant expression (V7) vector (figure 3.1). The 
quantity of nucleic acids prepared in different sections of chapter 3 was recorded in 
table 3.1. The junction of V7 vector to the fusion construct was read by sequencing 
(figure 3.3). The V7-ASP30API was introduced into Agrobacterium first so that the 
binary vector system of Agrobacterium was used for plant transformation. After 
plasmid preparation from Agrobacterium, two major binary vectors were isolated. 
One was large Ti plasmid (like genomic DNA) while another was small plasmid ( � 1 3 
kbp). They were indistinguishable by agarose gel electrophoresis. Therefore, the 
prepared plasmid mix was restriction digested with both Xbal and Xhol such that the 
large Ti plasmid was digested to become smear while the small plasmid would give 
out the fusion insert. By comparing the size of insert from Xbal-XhoI-cut V7-
ASP30API plasmid, the presence of the insert in Agrobacterium was demonstrated 
(figure 3.4). 
Table 3.1 Spectrophotometric measurement of RNA and recombinant plasmid DNA 
prepared from different sections of chapter 3. 
Name of recombinant plasmid DNA / RNA A260 / A280 ConcentrationOg/pil) Yield Og) 
V7 vector 1.737 
Putative V7- ASP30API 1 . 7 6 2 0 . 2 7 5 15.1 
F2 plant RNA of #3 3.200 
F2 plant RNA of #5 2.360 236.0 
F2 plant RNA of #12 2.500 250.0 
F3 plant RNA of #2 1.776 4.648 464.8 
F3 plant RNA of #3 1.766 2.468 246.8 
F3 plant RNA of #5 3 0 ^ 
F3 plant RNA of V7 LTIS 
Genomic DNA of V7 plant 2.050 2.635 1054.0 
F3 plant genomic DNA of #2 2.026 1.655 496.5 
F3 plant genomic DNA of #3 2.022 1.555 466.5 
F3 plant genomic DNA of #5 1.825 2.230 892.0 
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Figure 3.2 Restriction digestion of V7 and pET-ASP30API with Xbal and Xhol. 2\ig 
of uncut V7 vector (lane 1) was cut by Xbal alone (lane 2) or Xhol alone (lane 3) or both 
Xbal+Xhol (lane 4) in 40^1 Ix One-Phor-All buffer (Pharmacia) at 37°C for 2 hours. 2|^ g 
pET-ASP30API was also cut by Xbal+Xhol of the same conditions (lane 5). All digestion 
mixes were loaded on 1% sterile agarose gel with IxTAE buffer, resolved by agarose gel 
electrophoresis and visualized by ethdium bromide staining and U V illumination. M= Ikb 
plus DNA marker. The size of marker was indicated as nucleotide base pair (bp). The Xbal-
Xhol-cut V7 and pET-ASP30API (indicated by arrows) were excised from the gel to prepare 
putative V7-ASP30APL 
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CaMV 35S promoter > 
CGCCACTGNACGTAAGGGATGACGAAAAATCCCACTACCGTTCGCAAGACCTTCCTC 
TATATAAGGAAGTCATTTCATTTGGAGAGGACACGCTGAAATCACCAGTCTCTCTCT 
Xbal S t a r t 
CAAGCTCTAGAAATATTTTGTTTAACTTTAAGAAGGAGATATACATATGCACCATCA 








Figure 3.3 Nucleotide sequence of junction between V7 and fusion insert in V7-
ASP30API. The junction was sequenced by V7 sequencing primer. The primer was 
hybridized on specific sequence of CaMV 35S promoter and read through the junction 
between V7 vector and the his-tag P30 fusion insert. The Xbal recognization site, 
translational start codon (start), the histidine tag (6x his-tag) and the enterokinase cleavage 
site (enterokinase) was underlined. While part of the P30 sequence was indicated by bold 
letters. 
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Figure 3.4 Restriction digestion of pure V7-ASP30API and plasmid mix prepared 
from agrobacterium with Xbal and Xhol. 200ml bacterial culture of agrobacterium 
containing V7-ASP30API was prepared. Plasmids were isolated by Qiagen midi-plasmid 
preparation kit and eluted into 20^1 TioEo.i. 5[il plasmid mix (lane 2) and Ipg of pure V7-
ASP30API (lane 1) were digested by 4 units of Xbal and Xhol individually in 20|a1 Ix One-
Phor-All buffer (Pharmacia) at 37°C for 2 hours. lO i^l of the digestion mixes were loaded into 
1% agarose gel, resolved by electrophoresis, stained by ethdium bromide staining and 
visualized under UV illumination. M= Ikb plus DNA marker. The size of marker was 
indicated as nucleotide base pair (bp) and shown on the left. The fusion insert (ASP30API) 
was indicated by an arrow. 
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3.4.2 Screening of homozygous transgenic plants 
13 wild-type Arabidopsis thaliana Columbia-0 ectype (FO) were grown to 
flowering stage, numbered (no.l to no.l3) and subjected to vacuum infiltration. After 
vacuum infiltration, the plants (FO) were somehow infected with agrobacterium. As 
the selectable marker (NPTII) confered a dominant phenotype of kanamycin 
resistance, only those seeds containing V7-ASP30API germinated and developed into 
green transformants (Fl). While the non-transformed seeds would germinate, then 
exhibited yellow leaves and died eventually. Twelve plants produced transgenic 
offsprings except no. 7 plant. 
Most transgenic plants were expected to be hemizygous i.e. only one 
transgene integrated into particular locus. These hemizygous plants were self-crossed 
and resulted in both heterozygous and homozygous offsprings. If plant was integrated 
with a single insert into genome, it would exhibit antibiotic resistant phenotype 
according to mendelian fashion. Green to yellow plantlets was expected to be 3 to 1 
ratio and then analyzed by chi-square test. Green transformants (F2) with acceptable 
chi-square values were selected and allowed to propagate (table 3.2). 
These green transformants (F2) would either be heterozygous or homozygous. 
They were self-crossed to produce seeds. If F2 plant was heterzygous to the 
transgene, green and yellow plantlets would be produced and exhibited 3 to 1 ratio. If 
F2 plant was homozygous, all the offsprings would be green. These green 
transformants (F3) was regarded as pure homozygous plants. F3 plants of no. 11，12 
and 13 were needed for further screening and would not be used for analysis in 
following experiments. During this screening, homozygous lines were identified in 
no. 3 and 5 plants. While no. 2 F2 plant was found to be homozgous i.e. double 
insertion of transgene on the same locus. Therefore, three lines #2, #3 and #5 were 
used for further analysis. In addition, transgenic plants containing V7 vector 
integrated in plant genome was obtained from Dr. Lam. This V7 plant or control was 
used as negative control during molecular analysis of transgenic plants. 
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Table 3.2 Chi-square analysis of F2 transgenic plant. 
Numbered F2 plants Green : yellow plantlets y^  value Accept or Reject 
2 All green - Reject 
3 94:37 0.735 Accept 
5 91 :33 0.170 Accept 
11 88:24 0.762 Accept 
12 90:35 0.600 Accept 








3.4.3 Molecular analysis of transgene P30 in transgenic plants 
The presence of transgene in plant genome was demonstrated by polymerase 
chain reaction (PCR) on genomic DNA of transgenic plants (#2, 3，and 5) with 
specific primers. The presence of PCR products with expected size (279 bp) indicated 
the presence of transgene in genome of transgenic plants (figure 3.5). As the each 
infection event was independent, the integration site of transgene on each transgenic 
plant was different. Since positional effect of transgene might contribute different 
transcriptional and / or translational expression levels. The copy-number and position 
of transgene his-tag P30 was demonstrated by southern blot (figure 3.7). The 
restriction-digested DNA was hybridized with labelled probe. The DIG-labelled probe 
was estimated to be 25ng/pil (figure 3.6). Genomic DNA of transgenic plants was 
restriction digested with EcoRI or Hindlll overnight to ensure complete digestion. 
They were resolved by 0.8% agarose gel electrophoresis and then transferred into 
nylon membrane to hybridize with probe. In southern blot, the number of bands of 
digestion mix represented the number of transgene copy. In addition, different 
positions of transgene represented different integration sites of transgene in plant 
genome. 
Total RNA of transgenic plants were extracted. 20^ig RNA from each sample 
was resolved by 1% denaturing gel. The RNA transgene transcripts were detected on 
F2 transgenic plants (#3，#5，#12 and V7) by northern blot (figure 3.8). However, as 
the DIG-labelled DNA probe of P30 was not consistent in northern blot, reverse-
transcription polymerase chain reaction (RT-PCR) on F3 transgenic plants (#2，#3，#5 
and V7) was performed to demonstrate the transgene RNA expression. The mRNAs 
in total RNA of transgenic plant were reversely transcribed with oligo dT primer. The 
first-strand cDNA was then amplified by PCR with specific primers. To prevent false 
positive duo to genomic DNA contamination, total RNA was digested by DNase I. In 
addition, mRNA without reverse transcription was used as negative control. The 
presence of specific-size PCR product represented the RNA expression of transgene 
(figure 3.9). 
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As the RNA expression levels were comparible among three transgenic lines, 
the protein content of transgenic plant #3 was analysed to detect his-tag P30. Proteins 
were extracted by different conditions (pH 5 or 7 and with or without (3-
mecaptoethanol) and compared in SDS-PAGE gel (figure 3.10). An additional protein 
band of 30 kDa size was observed in 12% SDS-PAGE gel. This protein band was 
being investigated by N-terminal amino acid sequencing. In addition, proteins of F3 
plants of V7，#2，#3, and #5 were extracted by protein extraction buffer (pH 7.0). 
Western blot of protein extracts with seropositive serum of human was performed in 
which the bacteria-expressed his-tag P30 was used as control (figure 3.11). Except 
positive control, no obvious signal was detected. 
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Figure 3.5 PGR on genomic DNA of transgenic plants. S^g of genomic D N A from 
transgenic plants (#2，3, and 5) was used for PCR with specific primers (MF 457 and 458) 
(lane 1，2 and 3). Distilled water and l^ig of pure pET-ASP30API plasmid were used as 
negative and positive controls (lane 4 and 5). They were also amplified by PCR with specific 
primers. 1 5 o f the PCR products was then loaded on 1% agarose gel for electrophoresis. The 
gel was then stained with ethdium bromide and visualized under U V illumination. M = Ikb 
Plus D N A marker. The size of marker was indicated as base pair (bp) and shown on left. The 
specific-sized PCR prooduct ( - 2 8 0 bp) indicated the presence.of transgene in plant genome. 
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Figure 3.6 Estimation of DIG-labelled P30 probe with DIG control. 
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Figure 3.7 Agarose gel and Southern blot of restriction-digested genomic DNA of 
transgenic plants (#2, 3, and 5) with DIG-labelled P30. 25ng genomic DNA of F3 plants 
(#2，#3，and #5) was completely restriction digested by EcoRI (lane 1，2 and 3) or Hindlll 
(lane 4, 5 and 6). The digestion mixes were loaded by 0.8% agarose gel and resolved by 
electrophoresis (a). The gel was then transferred to nylon membrane and hybridized with 
DIG-labelled P30. Chemiluminescence was developed on hybridized probe on membrane by 
CSPD and the signals were detected by X-ray film (b). M = Ikb Plus DNA marker. The size 
of marker was indicated as base pair (bp) and shown in the middle . 
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Figure 3.9 Northern blot on transgenic plants with DIG-labelled P30 DNA probe. 
The RNA was extracted from the V7 and F2 (#5, #3 and #12) plants and resolved under 
denaturing condition (lane 1, 2, 3 and 4) of agarose gel electrophoresis (a). RNA was 
transferred to nylon membrane and hybridized with DIG-labelled P30 DNA probe. The 
membrane was then washed, developed with CSPD chemiluminscent substrate and exposed 
to X-ray film. The autoradiography was recorded and shown in (b). The arrow indicated the 
band from blot and its corresponding position in the agarose gel. 
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Figure 3.11 RT-PCR on transgenic plant RNA. Total RNA from F3 transgenic plants 
of #2 (lane 1 & 2)，#3 (lane 3 & 4) and #5 (lane 5 & 6) was extracted and digested with 
DNase I to remove any genomic DNA. It was reversely transcribed into first-strand cDNA by 
oligo-dT primer. These RT products were amplified by PCR (lane 2, 4 and 6). Negative 
control on each RNA sample was performed in which no MMLV-RT was added during RT 
(lane 1，3 and 5). M = Ikb Plus DNA marker. The size of marker was indicated as base pair 
(bp) and shown in the left. 
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Figure 3.12 Protein profiles of V7 and F3 transgenic plants in different conditions. 
Plants of V7 (lane 1, 3, 5 & 7) and #3 (lane 2, 4, 6 & 8) were frozen by liquid nitrogen and 
ground into powder. Proteins were extracted with protein extraction buffer either at pH 5 
(lane 1-4) or pH 7 (lane 5-8). At each pH, the buffer was either added with p-mecaptoethanol 
(lane 1-2 and 5-6) or not (lane 3-4 and 7-8). M= Broad-range protein marker (BioRad) was 
used. The size of marker was indicated as kDa and shown on left. 
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Figure 3.13 SDS-PAGE and western blot of proteins from homozygous transgenic 
plants. Proteins from F3 plants (V7, #2, #3，and #5) were extracted (lane 1, 2, 3 & 4) and 
loaded into 12% SDS-PAGE (a). The proteins were then transferred to PVDF membrane to 
perform western blot. The bacteria-expressed his-tag P30 on PVDF membrane was included 
in western blot as positive control (lane C). The membrane was then washed, developed with 
CSPD chemiluminscent substrate and exposed to X-ray film. The autoradiography was 
recorded and shown in (b). M= Broad-range protein marker (BioRad) was used. The size of 
marker was indicated as kDa and shown on left. 
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3.5 DISCUSSION 
3.5.1 Construction and optimization of expression construct 
The plant expression vector, V 7 � w a s u ed in this experiment. It contained a 
promoter derived from Cauliflower mosaic virus 35S RNA gene (Odell et al., 1985) 
and enhancer sequence (Kay et al., 1987). It drived high-level and constitutive 
expression of many heterologous genes (Benfey and Chua, 1990). The nospaline 
terminator was used for efficient termination and polyadenylation in the transgene 
transcripts. The neomycin phosphotransferase II (NPTII) was used as selectable and 
assay able marker (Reiss et al” 1984). It was used to express hepatitis B surface 
antigen in transgenic (Mason et al., 1992). 
Signals for efficient initiation of protein translation were important for 
transgene expression in plants. The 5'-untranslated leader (5'-UTL) sequence 
surrounding AUG start codon was important for efficient translation in plants. In 
addition, —3 (where A in AUG is +1) position was found to be purine (especially A) in 
most of vertebrate mRNA. While consensus guanine was also found at +4 and +5 in 
plants (Koziel et al., 1996). It suggested that these modifications should be considered 
in our construct. 
Plant viral mRNA such as viral coat mRNA could efficiently enhance 
translation. Because the UTLs competed effectively with plant mRNA. The 5，leader 
sequence of tobacco mosaic virus RNA (TMV) was used to express norwalk virus 
capsid protein in transgenic plant (Mason et al., 1996).，In addition, 5' leader of 
tobacco etch virus (TEV) was used to express CT-insulin for the treatment of 
autoimmune disease (Ma et al., 1997). On the other hands, the use of intron somehow 
increased transgene expression. Probably it increased the stability of the transgene 
transcript and thus enhanced the translational level of transgene. Addition of maize 
alcohol dehydrogenase 1 (Adhl) gene was generally used to optimize transgene 
expression. (Callis et al., 1987). 
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3.5.2 Screening and selection of homozyous transgenic plants 
Ecotype Columbia-0 of Arabidopsis thaliana had good efficiency for 
agrobacterium-mediated transformation by vacuum infiltration (Koncz and Schell� 
1986; Bechtold and Bouchez, 1995). The seeds were sowed on soil and necessary 
imbibded for germination. When the plants were grown to flowering stage at which 
the primary inflorescence was about 5-15 cm tall and the secondary inflorescence was 
just appearing. It was because agrobacterium infected plants at later stages of plants 
including zygote. Therefore, plants with flowering buds were used for infiltration 
(Bechtold et al., 1993). The method had been modified by Dr. Lam. The plants 
needed not be uprooted and inoculated into modified infiltration medium directly. A 
surfactant, silwet L-77, was added in the infiltration medium for effective 
transformation (Clough and Bent, 1998). 
After infiltration, most transgenic plants were expected to be independent and 
hemizygous (Feldmann, 1987). The majority of insertion segregated as one locus 
(Bechtold et al； 1993). Arabidopsis was able to self and cross pollination. Isolation of 
individual transformants enforced self-pollination. Therefore, independent 
transforaiants were recovered and allowed to self-cross to produce F3 progenies. 
According to Mendel's law of monohybrid inheritance, if F2 plant contained single 
transgene (T). Three-forth of the plants would exhibit dominant phenotype (green 
plantlet) in which they were either heterozygous (TO) or homozygous (TT). One-forth 
would exhibit recessive phenotype (00). They would become yellow plantlets under 
selection. After Chi-square analysis, green F2 transformants were allowed to grow 
and self-cross to produce pure F3 progenies (TT). In this experiment, five F2 plants 
with single transgene were isolated. Three of them (#2，#3 and #5) were propagated to 
F3 plants because other three were contaminated with fungi. Besides, a rare event 
happened during screening. Transgene was integrated at both and same alleles in the 
plant genome to produce homologous plant (#2) in F2 generation. 
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3.5.3 Analysis of transgenic plants 
The genomic DNA was extracted by CTAB method because CTAB salt was 
particularly to remove plant polysaccharides. These polysaccharides would oxidize 
DNA in samples. The presence of transgene in plant genome was checked by PCR 
with specific primers. The presence of specific-sized PCR product implied that the 
transgene had sucessfully integrated into plant genome. In addition, the genomic 
DNA was restriction digested by EcoRI and Hindlll and detected by P30 DIG-
labelled probe. The size and number of band corresponded to position and copy 
number of transgene in plant genome. The transgenic plants #2，3 and 5 contained one 
copy of transgene at different location. 
Furthermore, the transgene RNA expression of transgenic plants was detected 
by northern blot. The DIG-labelled P30 DNA probe was used in northern blot. The 
intensities of the bands represented transgene expression. The difference was 
probably duo to positional effect of the transgene in plant genome. However, northern 
blot was performed in F2 and F3 plants but it was not successful in F3 plants (data not 
shown). It was because DIG-labelled DNA probe was not suitable for northern blot. It 
could be improved by using RNA-labelled probe (Riboprobe) or DIG-labelled PCR 
probe (unpublished observation of Miss Cheng). 
Therefore, RT-PCR on F3 plants was performed. The genomic DNA in RNA 
was efficiently removed by RNase One digestion (data not shown). The DNA-free 
RNA was then reversely transcribed into cDNA by oligo dT primer and M-MLV 
reverse transcriptase. It was then amplified by PCR. The presence of specific-sized 
PCR products indicated RNA expression of transgenes in homozygous transgenic 
plants. The different amount of PCR produced in RT-PCR experiment was duo to the 
different degrees of degradation in RNA samples rather than differences in expression 
levels. 
Proteins from F3 plants were extracted and compared with FO plants. Protein 
profiles obtained from extraction buffers at different pH were compared. An 
additional protein band at 30 kDa was identified in F3 but not FO plants. This protein 
band could only be resolved at around 12% but not 15% SDS-PAGE (data not 
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shown). The size of recombinant his-tag P30 was hard to predict because a putative N 
glycosylation site was present in P30 gene (Burg et al” 1988). It was used in 
eukaryotic expression systems (CHO cells and yeast) (Biemans et al., 1998). Amino 
acid sequencing on the protein band was undergoing on this additional protein of F3 
plants. 
Western blot was performed on the protein lysate with seropositive serum of 
human and monoclonal anti-his-tag antibody (data not shown). However, no bands 
was found in the blot except positive control (bacteria-expressed his-tag P30). The 
negative result might be duo to the expression level of the protein was low so that the 
detection system was not sensitive enough to detect the his-tag P30. Besides, the 
protein was unstable in plant cytoplasm so that expressed protein had short life span. 
It disappeared during purification and therefore could not be detected. Finally, it 
might be no his-tag P30 expressed in plants by unknown reasons. 
If the expression level of his-tag P30 was low in plant. The crude protein 
extract of V7 and transgenic plants could be used to immunize mice and raise 
antisera. These antisera were used to probe bacterial-expressed his-tag P30. Positive 
signal indicated the presence of his-tag P30 in plants. Because large amount of protein 
extract can be used to immunize mice (up to 6 0 0 v o l u m e per mouse) and relatively 
small antigenic protein could elicit immune response of mice. It was a method worthy 
to try. 
Stability test on recombiant protein could be tried by using plant extracts and 
bacteria-expressed his-tag P30. If the protein degraded quickly in plant extract 
compared to standard protein buffer. It suggested that degradation was the major 
factors contributed to the production of recombinant protein. The stability of 
transgene product could be maintained by targeting proteins to compartment of plant 
cells. Transgene product, which was normally present in cytoplasm, could be targeted 
to plant vacuole by addition of a short C-teriminal sequence (Munro and Pelham, 
1987; Neuhaus et al, 1991). Expression of CTB-insulin was also targeting to plant 
vacuoles (Arakawa et al., 1998b). 
I l l 
Chapter 4 General Discussion 
4.1 Significances of studying Toxoplasma gondii 
Molecular biology had revolutionized our understanding on T. gondii (review 
by Boothroyd et al” 1995). With the establishment of in vitro culture (McHugh et al, 
1993; Soete et al., 1994), T. gondii was successfully transfected and became the first 
"transgenic" apicomplexan parasite (Soldati et al., 1993; Kim et al” 1993). This 
technology was applied to study the bradyzoite differentiation and stage-specific 
genes. By searching expression library and EST databases of bradyzoites, a lot of 
bradyzoite-specific genes were identified (Parmley et al.，1995; Yang and Parmley, 
1997; Manger et al” 1998b). Some of them were shown essential for differentiation, 
infection and cyst formation (Weiss et al” 1998; Hisaeda and Himeno, 1997; Zhang et 
al” 1999). Gene knockout and antisense mutants of these genes were useful to 
delineate the their functions (Mercier et al., 1998; Zhang et al., 1999). 
Studying invasion discovered that T. gondii had developed a specialized form 
of locomotion，called gliding (review by Sibley et at” 1998). T. gondii actively 
penetrated into host cells by its actinomysin motor and thrombospondin-related 
anonymous protein (TRAP)-like microneme protein 2 (MIC2) (Dobrowolski and 
Sibley, 1996; Dobrowolski et al, 1997; Wan et al., 1997). The actin-myosin present 
just beneath the membrane provided a scaffold for the attachment of discharged MIC2 
protein. Thus capping MIC2-myosin at anterior end through the movement of myosin 
along the actin filament resulted in forward movement. Understanding of these 
processes would contribute to the design of antitoxoplasma drugs (Morisaki et al” 
1995). 
By studying infection-related organelles (microneme, rhoptry and dense 
granules), a lot of secretory proteins as well as their functions were elucidated 
(Carruthers and Sibley, 1997; review by Dubremetz el al” 1998; Fourmaux et al., 
1996b). Some of them were suggested important for infection such as ROPl (Lycke et 
al, 1975; Schwartzman，1986; Ossorio et al., 1992; Soldati et al., 1995) and 
nucleoside triphosphate hydrolase (Asai et al., 1987; Asai et al., 1995). From the 
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study of immune response of toxoplasmosis, the cytokine circuits and the immune 
components of host response could be studied in details by means of animal model 
especially knockout mice of cytokines (Cox, 1997). Cellular mediated response (CMI) 
was important for host protection against toxoplasmosis (review by Denkers et al., 
1997; Gazzinelli et al., 1993). While cytokines could positively (interferon-aand 
TNF-a) or negatively (interleukin-lO and interleukin-12) affect the replication of 
parasite as well as the infection (Suzuki et al” 1988; Denkers and Gazzinelli, 1998; 
Denney et al, 1999). 
In addition, a new plastid-like organelle was firstly discovered in T. gondii by 
in situ hybridization (Wilson, 1993; McFadden et al., 1996; Baldauf et al., 1996; 
Lang-Unnasch et al., 1998). It was also present in Plasmodium falciparum (Wilson et 
al” 1996). This plastid contained essential genes for T. gondii but not present in host. 
Therefore, it was the main target for new therapeutic strategy (Fichera and R o o s� 
1997; Waller et al., 1998). P30-like GPI-anchored antigen was also found on the 
surface of Neospora caninum. N. caninum was a closely related apicomplexan 
parasite to T. gondii. It was an etiological agent of neosporosis and associated with 
abortion of dairy cattle. Therefore, study of T. gondii could improve our basic 
understanding of N. caninum and provide reagents valuable for diagnosis as well as 
future studies of neosporosis (Daneil et al” 1998). 
4.2 Expression of recombinant P30 in prokaryotic systems 
P30 was considered to have important role in both immune and pathogenic 
mechanisms of the parasite. It was the principal antigen recognized by seropositive 
sera (Kasper and Boothroyd�1993). In addition, PCR-based assay on P30 gene had 
been applied for clinical diagnosis (Ellis, 1998). P30 stimulated macrophage from 
seropositve individual to release high titer of ^-interferon (Suzuki, 1988; Khan et al” 
1988). Mice adoptively transferred with P30-specific splenocytes showed protective 
against challenge (Kasper et al., 1992). P30 was also able to induce toxoplasmocidal 
activity (Makioka and Kobayashi, 1991). 
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Several factors should be considered for the expression of recombinant P30. 
High production at low cost should be achieved. It was important before puting the 
product into market. Secondly, it should be antigenic when it was used as diagnostic 
agent or subunit vaccine. As such it was sensitive enough for screening of infected 
patients with small amount of sample or antigenic enough to elicit immunization in 
small dose. In addition, it should be “biological active" for biological assays in basic 
researches of T. gondii. 
P30 was isolated from expression library in which P30 was expressed as 
fusion protein (Burg et al., 1988). Since then a variety of bacterial expression systems 
had been tried (Kim et al., 1994). It included nonfusion systems (pOTS and pET) and 
fusion systems (Tip E of pATH system, glutathione S-transferase of pGEX system, 
and protein A of pRIT system). It was found that P30 was poorly expressed as a 
nonfusion protein. Although expression was more efficient in the fusion systems, 
none of the proteins produced by these systems could efficiently be recognized by 
antiserum generated against native P30. 
P30 was modified such that its hydrophobic N and C termini were removed. 
Besides, it was fused with a tag and expressed in E. coli. It could also be detected by 
monoclonal antibody recognizing only nonreduced native P30. It was used to detect T. 
gon^/ii-specific IgG and IgM in human sera. (Harning et al., 1996). Although the 
bacteria-expressed GST-fused P30 existed in a form of inclusion body, it could 
activate toxoplasmocidal activity of macrophage (Makioka and Kobayashi，1991b). 
Vaccination of bacteria-expressed P30 was protective against lethal challeng 
(Petersen et al., 1998; Letscher-Bru et al, 1998). 
His-tag P30 was expressed as 32 kDa protein in SDS-PAGE gel. It was 
produced over 20% of the total protein by IPTG induction. It could be purified by 
single-step TALON-resin purification. It contained epitopes of native P30 and thus 
could rise antibody for detection of P30 protein (35 kDa) in T. gondii lysate. These 
epitopes could recognize the antibodies from seropositive sera of human, mice as well 
as rabbits. These properties of his-tag P30 could be used as diagnostic agent or 
subunit vaccine. 
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As a rule, most bacteria-expressed P30 were abundantly produced but 
insoluble and misfolded (Makioka and Kobayashi�1991; Xiong et al” 1993). It was 
because P30 was a complex protein consisting of 12 conserved cysteines to maintain 
its complex secondary and tertiary structures (Kim et al” 1994). Optimization of 
producing his-tag P30 was preliminarily performed. The cost of purification could be 
reduced by differential centrifugation to obtain purified his-tag P30. Besides, the 
insoluble his-tag P30 could be refolded such that its antigenicity to antibodies of 
native P30 was greatly increased (unpublished observation of Dr. Chen). The result 
was promising but more tests should be done on optimizing the refolding conditions. 
Furthermore, proteolysis was observed during the purification. Strategies 
minimizing proteolysis to increase the yield of full-length polypeptide was reviewed 
(Murby et al” 1996). The his-tag P30 could be "exported" outside the bacteria where 
little proteases were present (Pugsley�1993). In addition, the N terminus of the 
recombinant protein should be considered for stability owning to the N-end rule 
(Bachmair et al” 1986; Tobias et al, 1991). The "activity" of his-tag P30 should be 
performed when the protein was used as subunit vaccine. The mice were immunized 
with his-tag P30 and then challenged with lethal or sub-lethal dose of T. gondii to see 
wheather immunization could offer any protective effect by means of survival time or 
brain cyst load. 
4.3 Expression of recombinant P30 in eukaryotic systems 
Sindbis virus was firstly used as vector to deliver fusion GST-P30 gene into 
eukaryotic BHK cells (Xiong et al., 1989; Xiong et al” 1993). The recombinant GST-
P30 was much more antigenic than those produced in E. coli for recognizing T. gondii 
lysate. Although the expression level was low, this recombinant sindbis vims could be 
developed as a live recombinant vector vaccine. Besides, his-tag P30 was produced by 
insect cell through infection with recombinant baculovirus (Chen et al” 1999). It 
could easily be purified by one-step Ni-NTA agarose to more than 95% purity. It 
could be recognized by antibody to native P30 and prolong the life span of immunized 
mice. 
115 
Conformationally appropriate expression of P30 was also performed in 
eukaryotic CHO cells (Kim et al” 1994). The transgene together with GPI anchor was 
integrated into eukaryotic cell genome and expressed on surface of CHO cells. By 
increasing selection pressure and cell sorting� the expression level of P30 was 
enhanced. The P30 could also recognize human sera reactive to Toxoplasma proteins. 
However, pure P30 could only be obtained by affinity column. The cost of large-scale 
production of P30 was prohibitive. On the other hand, P30 was expressed in 
methylotrophic yeast (Pichia pastoris) (Biemans et al., 1998). The hydrophobic C and 
N terimini of P30 gene was truncated. In addition, a a-mating factor prepro secretion 
signal sequence of Saccharomyces cerevisiae was fused to 3，end of P30 gene. 
Therefore, large amount of P30 was obtained by secretion of yeast. The P30 could 
induce T-cell proliferation and protect immunized mice from lethal challenge. 
Nevertheless, it showed incomplete processing, retention of 3，fusion partner and 
abnormal N glycosylation. 
This was the first report of using Arabidopsis to express P30. Because it had a 
short life cycle to see wheather the parasite gene could be expressed in plant. P30 
gene was introduced into plant genome by Agrobacterium-modiated transformation 
and vacuum infiltration. Some plant cells (including reproductive cells) were 
somehow infected so that the transgene was stably integrated into plant genome. 
Transgenic plants carrying P30 gene was selected under kanamycin resistant medium. 
Transgenic plants of F3 generation were obtained. They were expected to carry single 
copy of P30 gene in their genome at different locations. By using PGR and southern 
blot, the P30 gene in plant genome was detected. Single copy of transgene was 
selected because it allowed the screening according to mendelian law and thus made it 
much easier. On the other hand, the position of transgene might contribute to the 
differences in expression levels. By crossing of F3 plants, hybrids with 2 transgenes 
in plant genome allowed to see the gene dosage effect of transgene. 
Transgene RNA expression was detected in both F2 and F3 plants by northern 
blot and RT-PCR. Although no "housekeeping" gene was used to normalize the 
expression level of transgene, their levels of expressions were comparable. RNA 
116 
expression indicated that the expression cassette in plant expression vector was 
working in plant genome. Since the cassette allowed constitutive expression of 
transgene, the expression level of transgene during development of plant was more or 
less the same. By RT-PCR on different stages of F3 plants, transgene expression was 
more or less the same (data not shown). It implied that the transgene might not be 
toxic to the plant. Besides, the transgenes were located in plant genome where its 
expression would not be hindered by developmental changes of the plants. However, 
spatial expression on different parts of the same plant had not been done. Therefore, 
recombinant protein could first be obtained from particular parts of plant for 
purification. 
The result of expressing P30 protein in Arabidopsis was not apparent. Proteins 
were extracted by buffers of different pHs and compared among transgenic plants. 
Because most of the recombinant protein constituted less than 1% of the total protein 
(maximum load on SDS-PAGE was about 100 jig) in plant. Therefore, it was hard to 
observe the additional protein band in protein extract. By western blot with 
seropositive sera, no positive signal was detected in extracts of transgenic plants 
except positive control. The bacteria-expressed his-tag P30 was used to test the 
minimum amount of protein for a positive signal and found that at least 0.2 |Lig his-tag 
P30 was necessary (data not shown). Therefore, if the recombinant protein was 
expressed in plant, it should constitute less than 0.2% of the total protein in this case. 
By binding TALON resin with protein extract, a lot of proteins were found binding 
with resin. It might be a lot of histidine-rich proteins present in plant extract. Besides, 
the buffer conditions was not good for binding with TALON resin. However, after 
dialysis of resin binding buffer, the result remained the same (data not shown). 
Therefore, TALON resin was not suitable as an initial step for purification. 
Concentration of protein was necessary based on certain characterisitics of his-
tag P30. For example, the isoelectric point (pi) of the his-tag P30 was known so 
proteins could be concentrated by precipitation at pi. In addition, the size of his-tag 
P30 was known in bacteria so that size exclusion chromatography could be used to 
narrow down the proteins in plant extract. However, it should be noticed that the 
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In addition, the negative result of western blot on plant extract might indicate P30 was 
not expressed in plant. If this was the case, the major problem should be located at 
translation of transgene. As transgene RNA expression was demonstrated in F2 and 
F3 plants by northern blot as well as RT-PCR. The inappropriate optimization of plant 
expression construct such that translational initiation might contribute the 
translational block previously discussed in chapter 3. Therefore, in most case of 
sucessM example, a translational initiation seqeuence obtained from virus was 
included in the expression cassette. It was shown to greatly enhance the translational 
efficiency (Mason et al., 1992). Gene silencing could also cause no protein expression 
of transgene. Silencing occured either at the transcriptional level, frequently 
associated with DNA methylation, or post-transcriptionally�which involved RNA 
degradation (review by Vaucheret et al., 1998). Post-transcriptional transgene 
silencing (PTGS) was observed when foreign transgenes were introduced under the 
control of the strong viral 35S promoter (Elmayan and Vaucheret, 1996). 
Up to now, the his-tag P30 protein could not be detected from transgenic plant 
extracts. More works should be done to confirm whether the protein expression level 
of his-tag P30 was too low to be detected among the transgenic plants before drawing 
any conclusion. Heterologous expression of recombinant protein is an art of science. 
This particular discipline needs further explore and understand, especially when the 
pace of application is much faster than our understanding on these systems. 
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